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ABSTRACT
Background: Stroke is the second most common cause of death after cardiovascular 
diseases. Its prevalence in the young and middle-aged adults is increasing. Stroke 
is also the leading cause of disability worldwide. Especially in the young this is 
devastating due to their expected long lifespan. Low-income countries carry the 
biggest burden of growing numbers of stroke. In these countries infectious diseases 
play a major role in healthcare and well-being of patients. It is known that infections 
can trigger an acute stroke. It has not been investigated earlier how this affects the 
recovery from first-ever acute stroke in young adults. 
Finland is an industrialized North European country with a high-income level 
and well-organized public health care. Around 20% of the Finns live in the area of 
the capital, Helsinki, and its surroundings. Acute stroke care in the Helsinki area 
has earned world-wide reputation due to its excellency. Human immunodeficiency 
virus (HIV) prevalence in adults is very low: a little over 3000 victims in a population 
of 5.4 million.
Malawi is situated in Sub-Saharan Africa (SSA). It is an agricultural country with 
main income coming from tobacco and tea farming, According to the World Health 
Organization, Malawi is among the countries with the lowest human development 
index ranking 170 out of 187 countries. Blantyre is the second largest city after the 
capital, Lilongwe. In SSA such non-communicable diseases as high blood pressure, 
diabetes mellitus, epilepsy, cardiovascular diseases, and stroke are increasing. Their 
treatment has been neglected due to other challenges in healthcare, like infectious 
diseases and high infant mortality. Stroke occurs more in SSA in the younger age 
than in developed countries. In Malawi, non-communicable diseases cause 28% of 
deaths. Malawi is also highly burdened by the HIV epidemic. The HIV prevalence 
among young adults (aged 15-49 years) is 12%. Stroke outcome has not been studied 
earlier in Malawi or its neighboring countries. Neither is it known, how HIV infection 
influences stroke recovery.
HIV and acquired immunodeficiency syndrome (AIDS) was recognized over 30 
years ago. With the development of combined antiretroviral therapy (cART) during 
the mid-1990s the disease has changed from deadly to chronic condition with normal 
life span wherever good quality care is available. Although HIV-associated dementia 
(HAD) has become rare, HIV may cause milder neurocognitive impairments, which 
are called HIV-associated neurocognitive disorders (HAND) even with best available 
treatment.
Methods: The Helsinki Young Stroke Registry (HYSR) includes over 1000 
patients aged 15-49 years with first-ever acute ischemic stroke, who have been treated 
in the Helsinki University Central Hospital. We investigated how inflammation 
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affects recovery after stroke. In the first study, we investigated the factors associated 
with high leukocyte count and its impact on the 3-month and long-term functional 
outcome in patients from the HYSR. We included only patients who had their 
leukocyte count measured within two days of the stroke onset. In a separate study, we 
evaluated how infections affected the outcome of stroke in young patients with first-
ever ischemic stroke. We included both infections that occurred before the stroke 
i.e. preceding infections (PI), and in-hospital infections following the incidence i.e. 
post-stroke infections (PSI). Outcome was measured with modified Rankin Scale 
(mRS): if mRS was ≥2 it was considered unfavorable.
In Blantyre, we defined the characteristics and one-year outcome of first-ever 
ischemic or hemorrhagic stroke, and the impact of HIV infection on the stroke 
outcomes. The patients were diagnosed and treated in the Queen Elizabeth Central 
Hospital, which is the largest public hospital in the area. We included patients who 
arrived at the hospital within a week of the symptom onset. Their stroke severity was 
evaluated. Most patients underwent brain imaging and HIV testing. The patients 
were followed up for one year. The outcome was considered poor if mRS was ≥3. 
After 6 months or one year a selected subset of patients were interviewed about 
their quality of life with the Newcastle Stroke-Specific Quality of Life Measure 
(NEWSQOL).
In Helsinki, a group of HIV seropositive men were investigated three times: from 
between 1986 and 1990, in year 1997, very soon after the introduction of cART, and 
again in year 2013 in the Aurora hospital for infectious diseases. On each occasion 
they were invited for neurological, neurocognitive, radiological, and laboratory 
investigations to determine whether HIV infection has caused neurological or 
neurocognitive impairment following a very long follow-up with best available 
treatment. The Expanded Disability Status Scale (EDSS) was used to standardize 
the clinical neurological investigation. For neuropsychological examination several 
methods were used: subtests of Wechsler Adult Intelligence Scale (WAIS), and 
Wechsler Memory Scale-revised (WMS-r), list learning, fluency, Stroop and Trail 
– Making-B test. Depression was evaluated using the Beck Depression Inventory 
(BDI), and fatigue with fatigue severity scale (FSS). The three investigation-times 
were compared with relevant follow-up analyses.
Results: In Helsinki, 781 young patients from the HYSR were included in our 
study cohort of leukocyte count and ischemic stroke. Their mean leukocyte count 
was above the reference range: 8.8±3.1 x 109 cells/L (reference range: 3.4-8.2 x 109 
cells/L). Dyslipidemia, smoking, peripheral arterial disease, stroke severity, and 
infarct size were associated with higher leukocyte counts. High leukocyte count was 
independently associated with unfavorable 3-month outcome even after adjustment 
for age, gender, and relevant risk factors. In the long-term follow-up (8.1±4.2 years) 
no association was found to the initial leukocyte count. 
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Included in HYSR, were 681 patients who fulfilled the inclusion criteria for our 
study about infections and ischemic stroke. Of these, 70 patients (10%) had PI, 
most commonly upper respiratory tract infection, and 103 (15%) had PSI, most 
commonly pneumonia. After adjusting for gender, age, and risk factors, both PI (OR 
2.86; 95% CI 1.48-5.54) and PSI (OR 2.26; 95% CI 1.08-4.76) were independently 
associated with unfavorable 3-month outcome. Unlike PI, PSI was also associated 
with long-term (follow-up 7.8±4.0 years) higher risk of all-cause death.
In Blantyre, 147 adult patients with first-ever acute stroke were studied. The mean 
(±SD) age was 54.2 (±16.9) years. Among them, 26% had findings equivalent to 
intracerebral hemorrhage. Fifty (34%) patients were HIV seropositive. They suffered 
more often from ischemic stroke (89% of the patients with brain scan) than HIV 
seronegative patients. More than half (54%) of all patients had a poor outcome 
(severe disability or death) at 1-year, and the mortality rate was 45% at 1-year 
follow-up. Poor outcome was related to stroke severity and female gender but not 
to presence of HIV infection. HIV seropositive patients were younger and had less 
often conventional risk factors for stroke. 
Twenty-five Malawian stroke patients were interviewed with NEWSQOL 
interview. Good functional outcome was positively associated with better QOL on 
the domains of ADL/self-care (p <0.005) and ability for communication (p <0.05). 
Females scored worse on the domains of fatigue (p <0.01) and cognition (p <0.05). 
Older age was associated with worse QOL on the domain of ADL (p=0.012). Seven 
patients were HIV reactive. HIV infection did not affect the post-stroke QOL.
In Helsinki, the original 80 HIV seropositive patients were recruited to our 
study during 1986-1990, 23 were re-investigated in the 1997 evaluation, and 17 
participated in the year 2013 evaluation. Fifty-three of the patients had died in the 
intervening years, 10 were not able to participate the study in 1997 or 2013. The 
median (range) age of this all-male group was 57 (46-79) when the latest evaluation 
was made. They were diagnosed HIV seropositive 27 (23 to 30) years earlier. Their 
CD4 nadir was 170 (4 to 408) cells/mm3 (reference range for blood CD4 count: 
458-1406 cells/mm3). They were on cART for 13 (5 to 17) years. A third (29%) of 
them had signs of polyneuropathy (EDSS>3), and nine (53%) suffered from fatigue 
(FSS>37). There were no clinical signs of central nervous system impairment. The 
neuropsychological follow-up showed no effect of HIV infection. In MRI there was a 
subtle increase in brain atrophy in two men, and another three had signs of lacunar 
ischemic stroke, some already seen in 1997. BDI showed mild depression in all three 
investigation time points (mean 4.65, 5.53, and 5.00, respectively).
Conclusions: The high leukocyte count was common in young stroke patients 
in Helsinki. It was associated with vascular disease and stroke severity. The high 
leukocyte count was independently associated with unfavorable short-term, but not 
with long-term outcomes. Both PI and PSI were associated with poor short-term 
outcomes. PSIs were also associated with higher long-term mortality.
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In Malawi, more severe symptoms at the onset of stroke and female gender were 
associated with unfavorable 1-year outcome. HIV infection is common especially 
among young stroke patients in Malawi, but it does not worsen the outcome. 
However, it may be a risk factor for ischemic stroke for young people. Within specific 
domains, QOL after stroke was related to patients’ age, gender, and functional 
recovery.
Despite more than two decades of HIV infection, the surviving and aging Finnish 
male patients had no describing features of HAD or HAND while on best available 
treatment. Polyneuropathy, fatigue, and mild depression were common, but more 
severe neurological features were absent. The amount of silent strokes in our HIV-




Tausta: Aivoverenkiertohäiriöiden (AVH) esiintyminen nuorilla ja keski-ikäisillä 
on lisääntymässä. Ne ovat maailmanlaajuisesti merkittävin vammautumisen syy. 
Etenkin nuorilla, joilla pitäisi elämän olla vielä edessä, vammautuminen AVH:n 
seurauksena on katastrofaalista. AVH:t ovat myös toiseksi yleisin kuolinsyy maail-
massa heti sepelvaltimotaudin jälkeen. AVH:n yleisyyden kasvaminen on nopeinta 
kehittyvissä maissa. Näissä maissa tarttuvat taudit muodostavat usein merkittä-
vän haasteen terveydenhuollolle. Tulehdustautien tiedetään joskus käynnistävän 
AVH:öön johtavan tapahtumaketjun. Nuorilla AVH-potilailla ei ole tietääksemme 
aiemmin tutkittu, miten tulehdustaudit vaikuttavat akuutin AVH:n lyhyt- ja pit-
käaikaisennusteeseen.
Malawi sijaitsee Saharan eteläpuolella, keski-eteläisessä Afrikassa. Blantyre on 
Malawin toiseksi suurin kaupunki. Maailman terveysjärjestön inhimillisen kehi-
tyksen indeksillä mitattuna Malawi sijoittuu 170. sijalle 187 maasta. Pitkäaikaiset 
tarttumattomat taudit, kuten verenpainetauti, epilepsia, diabetes, sydänsairaudet ja 
AVH:t ovat yleistymässä Saharan eteläpuolella. Näiden maiden terveydenhuollolla 
on paljon muitakin haasteita, kuten tartuntataudit ja korkea lapsikuolleisuus. Siksi 
pitkäaikaiset sairaudet jäävät usein huomioimatta. AVH:öön sairastutaan kehitys-
maissa nuorempana kuin rikkaissa maissa. Malawissa pitkäaikaissairaudet aihe-
uttavat 28% kuolemista. Afrikan HIV-epidemia (human immunodeficiency virus) 
koskettaa Malawia. Nuorista aikuisista (15-49 -vuotiaista) 12%:lla on HIV-tartunta. 
Malawissa tai sen naapurimaissa ei ole aiemmin tutkittu AVH:iden ennustetta. 
Myöskään HIV-tartunnan vaikutusta AVH-potilaan ennusteeseen ei tiedetä. 
Suomessa AVH:n akuutti hoito ja uusien tapahtumien ehkäisy on järjestetty laa-
dukkaasti. HIV:n esiintyvyys on hieman yli 3000 tapausta koko Suomen väestössä. 
Lisäksi arvioidaan, että noin 1000 henkilöä ovat tietämättömiä tartunnastaan. HIV 
on tunnettu jo yli 30 vuoden ajan. Tehokas hoito siihen saatiin käyttöön vuoden 
1996 puolivälissä. HIV-dementia on tehokkaan lääkityksen myötä käynyt hyvin 
harvinaiseksi. Kuitenkin tehokkaimmankin hoidon aikana osa potilaista kehittää 
dementiaa lievempiä kognitiivisia oireita.
Menetelmät: Helsingin nuorten aivoinfarktipotilaiden rekisteri sisältää tiedot 
yli tuhannesta 15-49 -vuotiaasta nuoresta aikuisesta, jotka ovat sairastuneet en-
simmäistä kertaa akuuttiin aivoinfarktiin, ja jotka ovat hoidetut Helsingin yliopis-
tollisessa keskussairaalassa vuosina 1994-2007. Kävimme läpi rekisterin potilaat 
ja arvioimme, miten tulehdukselliset tilat vaikuttavat aivoinfarktin ennusteeseen. 
Tutkimme, mitkä tekijät aiheuttavat aivoinfarktipotilaalla korkeaa valkosoluarvoa 
sekä miten se vaikuttaa nuorten aivoinfarktipotilaiden lyhyt- ja pitkäaikaisennustee-
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seen. Otimme rekisterin potilaista mukaan ne, joiden valkosoluarvo oli määritelty 
kahden vuorokauden kuluessa aivoinfarktiin sairastumisesta. 
Toisessa tutkimuksessa selvitimme, miten tulehdussairaudet vaikuttavat nuor-
ten aivoinfarktipotilaiden ennusteeseen. 
Malawissa halusimme selvittää sekä aivoinfarktin että aivokudoksen sisäisen 
verenvuodon piirteitä, selvittää AVH:n ensimmäisen vuoden ennustetta sekä sitä, 
onko HIV-tartunnalla vaikutusta ennusteeseen. Tutkimme myös elämänlaatua ja 
AVH:n vaikutusta potilaan elämäntilanteeseen. Potilaat hoidettiin Blantyren seudun 
suurimmassa yleisessä sairaalassa, Queen Elizabeth Central Hospital:ssa. Tutki-
mukseen otettiin potilaat, jotka olivat saapuneet hoitoon viikon sisällä AVH-oireiden 
alusta. Oireiden vaikeusaste arvioitiin ja useimpien potilaiden aivot kuvannettiin ja 
selvitettiin, onko heillä HIV-tartunta. Potilaiden toimintakykyä seurattiin vuoden 
ajan. Puolen vuoden tai vuoden kohdalla osalle potilaista tehtiin elämänlaatukyse-
ly NEWSQOL-haastattelulla (Newcastle Stroke-Specific Quality of Life Measure).
Helsingin Auroran sairaalan tartuntatautien poliklinikalla on seurattu ryhmää 
HIV-infektoituneita potilaita vuosina 1986-1990 sekä vuonna 1997. Kutsuimme 
heidät 2013 uudelleen neurologisiin ja neuropsykologisiin selvittelyihin sekä aivojen 
magneettitutkimukseen (MRI) ja laboratoriotesteihin, koska halusimme selvittää, 
vaikuttaako vuosikymmeniä sairastettu HIV heidän neurologiseen tilaan tai kog-
nitioon. Käytimme EDSS-asteikkoa (Expanded Disability Status Scale) neurologi-
sen kliinisen kuvan arvioimiseksi. FSS-asteikkoa (Fatigue Severity Scale) käytettiin 
väsyvyyden arvioimiseksi. Neuropsykologinen tutkimus sisälsi kaikkina kolmena 
tutkimuskertana useampia eri menetelmiä, muun muassa WAIS-älykkyystestiä 
(Wechsler Adult Intelligence Scale) ja WMS-R- muistitestiä (Wechsler Memory 
Scale – revised) sekä sujuvuutta, oppimista ja toimintakykyä mittaavia testejä. Ai-
vojen MRI-tutkimusta verrattiin 1997 otettuihin kuviin.
Tulokset: Helsingissä 781 nuorten aivoinfarkti-rekisteriin kuuluvaa otettiin 
mukaan valkosoluarvo- ja aivoinfarktitutkimukseen. Heidän valkosoluarvonsa oli 
keskimäärin viitealueen yläpuolella: 8.8±3.1 x 109 solua/L (viitealue: 3.4-8.2 x 109 
solua/L). Korkea kolesteroliarvo, tupakointi, ääreisverenkierron sairaus (kuten val-
timokovettumatauti), akuutin vaiheen vaikeaoireisuus, ja aivoinfarktin suurempi 
koko nostivat valkosoluarvoa. Vaikka ikä, sukupuoli ja merkittävät riskitekijät otet-
tiin huomioon, korkea valkosoluarvo ennusti riippumattomasti kolmen kuukauden 
epäsuotuisaa ennustetta. Akuutin vaiheen valkosoluarvo ei vaikuttanut AVH:n pit-
käaikaisennusteeseen (seuranta 8.1±4.2 vuotta). 
Nuorten aivoinfarktirekisteristä 681 potilasta soveltui tulehdus- ja aivoinfark-
titutkimukseen. Näistä 70:llä (10.3%) oli aivoinfarktia edeltävä tulehdustauti, ylei-
simmin ylempien hengitysteiden tulehdus ja 103:lla (15.1%) aivoinfarktin jälkeinen 
tulehdustauti, tavallisimmin keuhkokuume. Sekä aivoinfarktia edeltävät (OR 2.86; 
95% CI 1.48-5.54) että aivoinfarktin jälkeen (OR 2.26; 95% CI 1.08-4.76) sairastetut 
tulehdustaudit vaikuttivat epäsuotuisasti aivohaverin kolmen kuukauden ennus-
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teeseen, riippumatta potilaan iästä, sukupuolesta tai tavallisimmista riskitekijöistä. 
Aivoinfarktia seuranneet tulehdustaudit huononsivat myös pitkäaikaisennustetta 
(seuranta 7.8±4.0 vuotta).
Blantyressa tutkimukseen otettiin mukaan 147 aikuista AVH-potilasta. Heidän 
keski-ikänsä oli 54.2 (±16.9) vuotta. Kuvatuista 26%:lla todettiin aivokudoksen 
sisäinen verenvuoto. HIV-infektio löytyi 50 (34%) potilaalta. Heillä iskeeminen 
aivoinfarkti oli yleisempi (89% kuvannetuista potilaista) aivokudoksen sisäiseen 
verenvuotoon verrattuna. Hieman yli puolella potilaista (54%) oli epäsuotuisa ai-
vohaverin jälkeinen sairaudenkulku: he jäivät vaikeasti vammautuneiksi tai meneh-
tyivät (45%) sairauteensa. Huono ennuste liittyi AVH:n akuutin vaiheen oireiden 
vaikeuteen ja naissukupuoleen, mutta HIV ei vaikuttanut ennusteeseen.
NEWSQOL-haastattelu tehtiin 25 aivohaveripotilaalle 6-12 kuukautta tapahtu-
man jälkeen. Suotuisa toipuminen liittyi potilaan itsenäisyyteen ja omatoimisuuteen 
(p<0.005) sekä kommunikaatiokykyyn (p < 0.05), korkea ikä heikensi elämänlaa-
tua omatoimisuuden ja itsenäisyyden osalta (p < 0.05). Naiset kokivat enemmän 
väsymystä (p < 0.01) ja kognitiivisen tason laskua (p < 0.05). Haastatelluista 7 oli 
HIV-positiivisia. Sillä ei ollut vaikutusta elämänlaatuun aivohaverin jälkeen. 
Yhteensä 80 suomalaista HIV-positiivista henkilöä otettiin tutkimukseen vuo-
sina 1986-1990. Heistä 23 osallistui uudelleen tutkimuksiin vuonna 1997. Vuonna 
2013, 17 miestä tutkittiin jälleen. Viimeisen tutkimuksen aikana heidän mediaani-
ikänsä oli 59 (46-75) vuotta. HIV-infektio oli diagnosoitu 27 (23-30) vuotta aiemmin. 
Heidän vastustuskykyä mittaavat solunsa, CD4 lymfosyytit olivat alimmillaan 170 
(4-408) solua/mm3 (viitealue CD4 solut: 458-1046 solua/mm3). He olivat saaneet 
cART-lääkitystä 13 (5-17) vuotta. Kolmanneksella miehistä (29%) oli polyneuropati-
aan viittaavat kliiniset löydökset (EDSS >3). Yli puolet (53%) koki itsensä väsyväksi 
(FSS>37). Yhdellä potilaalla oli extrapyramidaaliseksi sopiva oireisto, muutoin klii-
nisessä neurologisessa tutkimuksessa ei havaittu keskushermostoperäisiksi sopivia 
oireita. Lakunaarisia aivoveritulppia löytyi kolmen HIV-potilaan MRI-kuvauksessa. 
Osa niistä näkyi jo 1997 tutkimuksessa. Kolmella potilaalla aivoatrofia oli hieman 
lisääntynyt verrattuna 1997 tutkimukseen. Neuropsykologisessa selvittelyssä ei ha-
vaittu kognitiiviseen sairauteen viittaavia muutoksia. 
Yhteenveto: Nuorilla aivoinfarktipotilailla korkea leukosyyttiarvo oli tavalli-
nen löydös. Verisuonisairaudet ja vaikea aivoinfarkti nostivat valkosoluarvoa. Kor-
kea valkosoluarvo huononsi kolmen kuukauden ennustetta, mutta ei vaikuttanut 
pitkäaikaisennusteeseen. Myös tulehdustaudit huononsivat aivoinfarktin kolmen 
kuukauden ennustetta, mutta vain aivoinfarktin jälkeiset tulehdustaudit vaikuttivat 
potilaiden pitkäaikaisennusteeseen. Naissukupuoli ja vaikeat oireet huononsivat 
akuutin aivoverenkiertohäiriön jälkeisen vuoden ennustetta malawilaisilla potilailla. 
HIV-tartunta on tavallinen löydös nuorilla AVH-potilailla, mutta se ei vaikuta hei-
dän ennusteeseensa. HIV-tartunta voi kuitenkin olla nuorilla aikuisilla aivoinfarktin 
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riskitekijä. Potilaan korkeampi ikä, naissukupuoli ja AVH:n jälkeinen toimintakyky 
vaikuttivat heidän kokemaansa elämänlaatuun.
Seurantatutkimuksemme mukaan yli kaksi vuosikymmentä kestänyt HIV-in-
fektio ei altista Suomessa hoidettua potilasta HIV:in liittyviin neurokognitiivisiin 
ongelmiin eikä HIV-dementiaan, jos he ovat saaneet parasta tarjolla olevaa hoitoa. 
Vaikka polyneuropatia, väsyvyys ja alakuloisuus olivat tavallisia, keskushermosto-
peräiseen sairauteen viittaavia löydöksiä ei ollut. Pienen aineistomme aivoinfarktit 
tukevat muiden tutkimusten tuloksia: HIV on etenkin aivoinfarktien riskitekijä.
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1 INTRODUCTION
Stroke is an important cause of death and disability worldwide. Its importance in 
the low-income regions of the world has been notified during the last few decades. 
The Global Burden of Disease estimates that more than 80% of the all stroke deaths 
occur in low- and middle-income countries.1 The World Health Organization (WHO) 
defines stroke as: “rapidly developing clinical signs of focal (or global) disturbance 
of cerebral function, with symptoms lasting 24 hours or longer or leading to death, 
with no apparent cause other than of vascular origin.”2 The definition includes 
ischemic and hemorrhagic strokes as well as subarachnoidal hemorrhage. Ischemic 
stroke covers 80-85% of all strokes.3 Etiology, risk factors, and outcome of stroke in 
young adults usually differ considerably compared to those seen in older individuals.
The Trial of Org 10172 in Acute Stroke Treatment (TOAST) is one of the 
most commonly used etiologic classifications of ischemic stroke.4 In TOAST, 
stroke etiologies are divided into five categories: 1) large artery atherosclerosis, 
2) cardioembolism, 3) small vessel disease, 4) other determined etiology, and 5) 
undetermined etiology. Especially young patients often lack traditional risk factors 
or diseases that could trigger their stroke. These strokes are called ‘cryptogenic’. 
During the last two decades there are several studies that have evaluated the 
functional outcome and mortality of the young stroke patients. In the different 
studies, different types of strokes are included, all of them usually including ischemic 
strokes, but some also TIA or intracranial hemorrhages. The age-limits for young 
stroke and the definition of favorable outcome vary making it difficult to compare 
the studies to each other. The most widely used rating scales for functional outcome 
are the Barthel Index since year 1965 and modified Rankin Scale (mRS) of which 
original version was published in 1988.5-7
The role of infections as a cause of stroke and influencing the stroke outcome 
after stroke is highlighted more amongst the young stroke victims. This is because 
they have not developed the conventional risk factors yet. The burden of infectious 
diseases is even higher in developing countries where the stroke incidence is 
increasing.
The activity of HIV infection is measured with blood CD4 count and amount 
of HI-virus in serum. CD4 T-helper cells are a type of white blood cell. Nadir CD4 
indicates the lowest blood CD4 count measured during the course of HIV infection. 
HIV has the potential to cause ischemic stroke especially in young patients.8 
Predictions indicate that ischemic heart disease and cerebrovascular disease will 
overtake HIV/AIDS as a cause of death by 2030 in Sub-Saharan Africa.9
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2 REVIEW OF THE LITERATURE
2.1 ISCHEMIC STROKE IN YOUNG ADULTS 
2.1.1 Incidence of stroke in young adults
In the literature the cut-off age for the young adult in stroke studies varies from 40 
to 55 years of age. Approximately 5-8% of all ischemic strokes occur in individuals 
younger than 45 years.10-12 Above the age of 45 years the occurrence of stroke 
starts to increase exponentially.13 Around one quarter of strokes are caused by 
non-conventional or uncommon causes. The proportion of young stroke victims 
is likely to be higher in low-income regions like Sub-Saharan Africa (SSA) where 
the overall mortality is high and stroke in general occurs at a 10 year younger age 
than in the Western world. 
The most common cause of stroke is brain infarction. In young stroke victims, 
however, the proportion of hemorrhages, subarachnoid hemorrhage (SAH) or 
intracerebral hemorrhage (ICH), is greater (40–55%) compared to the general 
stroke population (15–20%).14 In this review the analysis concentrates on ischemic 
stroke.
2.1.2 Risk factors of stroke in young adults
The traditional vascular risk factors, most commonly hypertension, smoking, 
diabetes mellitus (DM), dyslipidemia and obesity, accumulate with age and are 
more common in males in young stroke populations.13 In developing countries, 
urbanization and increasing smoking rates are causing increased levels of strokes 
even in the younger generation.15 Men are older when stroke occurs and often have 
clustering of multiple vascular risk factors.16,17 In the young especially, smoking and 
dyslipidemia with high total and low-density lipoprotein levels, and low high-density 
lipoprotein level, are important risk factors (table 1). According to two recent large 
European young stroke registries, the most frequent vascular risk factors in the 
young are current smoking (49-56% of the patients), physical inactivity (48%), 
hypertension (36-47%), dyslipidemia (35-46%) and obesity (22%).16,17 The vascular 
stroke risk factors are often less severe in this age group and have not yet caused 
severe damage on the cerebrovascular system or heart. Individuals younger than 
40 years rarely have overt large-artery arteriosclerosis as a cause of their stroke.18
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2.1 Ischemic stroke in young adults 
Stroke is more prevalent in men than women in all age groups apart from those 
who are younger than 35-year-old and those older than 85 years.18,27 Increasing 
age is increasing the risk of stroke markedly in early midlife, and in men.13 Other 
non-modifiable risk factors are ethnic factors, low birth weight, and genetic factors 
like congenital hypercoagulopathy, sickle cell anemia, and occurrence of ischemic 
events in family.27,28 Young people from black, and Hispanic races have a greater 
stroke incidence.29,30 Sickle cell disease, in which 7 to 10% of affected individuals 
experience stroke before the age of 20,31 and other single gene disorders as a cause 
of stroke often manifest at a younger age.28
Modifiable and well-documented risk factors, other than conventional risk 
factors, are dietary factors, obesity, physical inactivity, and postmenopausal hormone 
replacement therapy.32 The risk effect of abdominal obesity seems to be higher in 
young stroke patients than in older, more than 65-year-old, stroke victims.33 In 
Danish men, obesity (BMI ≥30 kg/m²) was associated with a risk of stroke before 
the age of 55.34
Inflammatory processes and infections as a risk factor will be discussed later (2.3).
In women, puerperium, pregnancy, postpartum period, and oral contraceptive 
use increase the risk of ischemic stroke.16,18,35 Migraine with aura prevalence and 
its female predominance in younger stroke patients supports the hypothesis of 
its importance in the pathogenesis of ischemic stroke in very young females. The 
absolute risk increase is low, and association between common migraine (migraine 
without aura) and stroke is not clear.36 The under 35-year-old female stroke victims 
have often a physically inactive lifestyle.16 Griffiths and Sturm have published a list of 
the other less common causes of stroke that are more common in women: “systemic 
lupus erythematosus (SLE), antiphospholipid antibody syndrome (APLAS), central 
venous thrombosis (CVT), reversible cerebral vasoconstriction syndrome (RCVS), 
Susac’s syndrome, Takayasu’s arteritis, Moyamoya disease, Sneddon’s syndrome, 
and fibromuscular dysplasia”.37
The other risk factors are illicit drug use, heavy drinking and binge drinking, and 
short sleep duration.16,18,35 Illicit drug use or drug abuse refers to recreational use of 
prohibited substances, like cannabis, cocaine, amphetamine, sedatives, opiates, and 
certain inhalants. The majority of all users are young. The use of injectable drugs 
makes the user vulnerable to infections. The link between stroke and drug use is 
strongest for cocaine and amphetamines.38 Amphetamine abuse was associated 
with a 5-fold risk of hemorrhagic stroke and increased mortality. Cocaine abuse 
can cause both ischemic and hemorrhagic strokes. The most widely used drug, 
cannabis has not been confirmed as a risk factor for vascular events. However, 
there is a temporal relationship between its use and stroke in a study from New 
Zealand.39 Binge drinking or acute heavy drinking is a risk factor for both ischemic 
and hemorrhagic stroke in young adults.35,40,41
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Many young stroke patients remain without a definite cause or even a known 
risk factor for their stroke. On the whole, the interactions of several risk factors 
may be more important than a single risk factor since the simultaneous effect to 
the pathogenesis of ischemic stroke becomes more significant.18 The accumulation 
of modifiable risk factors at the young age should lead to effective preventative 
measures already at the age group of adults in their 30s or even earlier.
2.1.3 Causes of ischemic stroke in young adults
Many vascular risk factors activate the vessel endothelium and thus cause 
inflammation leading to arteriosclerosis in the later age.42,43 Consequently, large 
vessel atherosclerosis, atrial fibrillation, and small-vessel occlusion (TOAST 
categories 1-3) which are the main causes of stroke in general population, are less 
common in young stroke patients.13 On the contrary, cervical artery dissection 
(CAD), vasculitides, coagulopathies, and hematological conditions (TOAST category 
4, other determined causes of stroke) occur more in the younger population of 
stroke patients. 
CAD is the most common cause of ischemic stroke in the young causing 15-24% 
of all the ischemic strokes in this age group.22,24,44 According to a Finnish stroke 
study of dissection, CAD occurred as commonly in the internal carotid artery as in 
vertebral artery.45 CAD in the multiple sites occurred in 13-16% of cases.46 Many 
CAD remain without any symptoms.47 The mean age of CAD patients is 45 years. 
Common predisposing factor for dissection is cervical trauma but many cases occur 
spontaneously.48 Hypertension might increase the risk of dissection. Several genetic 
and environmental risk factors can possibly cause dissection. According to study by 
Pfefferkorn et al these patients might have generalized higher risk of inflammatory 
arteriopathy.49
The mitral valve heart disease is an important a cause of cardioembolic stroke 
in some populations while in others, like in many industrialized countries, it has 
virtually disappeared with an extinction of rheumatic valve disease.18,37 This is 
causing, for example as many as 32% of cases of young ischemic stroke in Iran.50 
Often related to rheumatic valve disease but also caused by excessive alcohol abuse 
or other reasons, and causing 2-20% of the cardioembolic strokes in the young, 
is atrial fibrillation.14,15,18 In South America a prevalent cause of cardiomyopathy, 
intramural thrombus, and cardioembolic stroke is Chagas disease.51 Trypanosoma 
cruzi- protozoan causes this disease, also known as American trypanosomiasis, 
using blood-sucking insects as a vector.
Patent foramen ovale (PFO) is a remnant of the fetal circulatory bypass of the 
lungs. It is an opening between the right and left atrium. PFO is common, occurring 
in a quarter of the adult population. PFO is considered to play a role in ischemic 
stroke in the young, mainly when no other reason is found, but its role is still 
controversial.16,37
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2.2 STROKE IN SUB-SAHARAN AFRICA
2.2.1 Introduction of Malawi and Sub-Saharan Africa
Figure 1. The map of Malawi. Source:http://www.norwich-dedza.org/images/malawi.gif.  
Reprinted with publisher’s permission.
Malawi (Figure 1) is a landlocked country in central southern Africa; neighboring 
countries are Mozambique, Zambia, and Tanzania. One-third of the country is water, 
Lake Malawi. Malawi’s main income source is agriculture, while the country’s main 
exports are tobacco and sugar.52 Half of the 15.9 million inhabitants of Malawi 
(51%) live below the national poverty line.53 
Sub-Saharan Africa (SSA) is the term used to describe all of the countries that are 
located south of the Sahara (Figure 2). The population of SSA is 910 millions.53 The 
annual population growth rate is 2.3% and the population is young: more than 40% 
is younger than 15 years.54  SSA suffers still commonly of the high child mortality rate, 
infectious diseases including malaria, and malnutrition.55,56 The southern part of the 
SSA is hit hard by the HIV/AIDS epidemic. The burden of disease in these countries, 
however, is moving from infectious diseases towards non-communicable diseases: 
contribution to the burden is increasingly in vascular diseases like stroke, high 
blood pressure or diabetes. The region is under health and demographic transition, 
which is caused by rapid urbanization, developing economy, and aging. The number 
of persons aged above 65 years is expected to increase by 15% in 2015. At present, 
37% of the SSA population lives in urbanized areas.53 
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Figure 2. Sub-Saharan African countries (in green). Source: Connor MD, Walker R, et al. Burden of 
stroke in black populations in Sub-Saharan Africa. Lancet Neurol 2007;6:269-278. Reprinted with 
publisher’s permission.
Figure 3. Age-standardized stroke-incidence per 100 000 person-years for 2010. Source: Feigin 
VL, Forouzanfar MH, et al. Global and regional burden of stroke during 1990-2010: findings from 




2.2.2 Incidence of stroke in Sub-Saharan Africa
Despite the growing numbers of stroke patients in SSA (Figure 3), little is yet known 
about the incidence of the disease.56,57 One of the first community-based studies in 
SSA occurred before the era of brain scanning, and took place in Ibadan, Nigeria. 
The study stuff was very small and the population of Ibadan very mobile, therefore, 
an underestimation is likely in the results of incidence of first-ever stroke (15 per 
100 000).58,59 The hospital-based stroke incidence studies easily underestimate the 
true incidence rate of the population. They have shown, however, a steady increase 
of the incidence. In Accra, the capitol of Ghana, stroke admissions were evaluated 
in three periods in 1960-68, 1976-83, and 1990-93 during which time total stroke 
admissions increased from 2% to 12%.60 Further southern African studies from 
Zimbabwe and South Africa estimate the stroke crude incidence rate to be 31 per 
100 000 (standardized to world population: 61/100 000) and 101 per 100 000, 
respectively.61,62 Both studies showed marked age-related increase in the incidence. 
The comparison of these incidence rates with the rest of the world is difficult due 
to different study methods. In Finland the incidence rate for strokes have been one 
of the highest in the world (>2000/100 000 in 2002), but in recent decades there 
is a positive decline in this (more than 2% annually).63 In middle to low-income 
countries the incidence has increased by 100% in first decade of this millenium.64
Recently, two further community-based studies were carried through: one 
in urban Nigeria, where the incidence was 25 per 100 000.65 The other study in 
Tanzania, a prospective community-based survey, was done both in rural Hai 
and urban Dar es Salaam.66 The incidence rates were 95 per 100 000 (95% CI 
76.0–115.0) in Hai and 108 per 100 000 (88.1–129.8) in Dar es Salaam. When 
age-standardized to the WHO world population, the yearly stroke incidence rates 
were 109 per 100 000 (95% CI 89.0–130-9) in Hai and 316 per 100 000 (281.6–
352.3) in Dar es Salaam. The Tanzanian study population was compared to the 
black population in Manhattan Stroke Study.67 The rural Tanzanian population 
had similar incidence rate than urban black population in Manhattan while the 
incidence in urban Tanzania was substantially higher (Figure 4).
2.2.3 Features of stroke in Sub-Saharan Africa
In industrialized countries the prevalence of stroke is declining while in SSA it 
is increasing.64,68 As SSA continues urbanizing and its population gets older, the 
prevalence of vascular diseases will increase. At present, the prevalence of stroke 
is lower than in developed countries but SSA stroke patients when compared 
with patients in wealthy countries have a less favorable recovery.69,70 Age-adjusted 
stroke mortality is even higher than in the Western world.57,71 Stroke is affecting 
people at a much younger age in SSA.72-74 ICH is more prevalent in SSA and causes 
one third of the strokes (27-31%).72,75,76 In a Senegalese study the proportion of 
2.2 Stroke in Sub-Saharan Africa
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ischemic stroke was 65% and ICH 35%.77 This proportion is higher than in any 
other part of the world. In a Tanzanian study the incidence rates of ischemic versus 
hemorrhagic stroke were similar to those in many developed countries: 83% and 17% 
respectively.78 The scarcity of CT-scans in the region makes it difficult to estimate 
the stroke-type (infarction vs. hemorrhage) in many regional hospitals. Even when 
CT-scans are available, they frequently are out of order.
Figure 4. Age-specific stroke rates for people aged 45 years or over in Hai, Dar es Salaam, and 
black people in Northern Manhattan. Walker R, Whiting D, et al. Stroke incidence in rural and 
urban Tanzania: a prospective, community-based study. Lancet Neurol 2010;9:786-792. Reprinted 
with Publisher’s permission.
When black people are compared with other ethnic groups, they have a higher 
prevalence of hypertension and at a younger age.79 They are more likely to be 
salt-sensitive, have a low plasma renin activity, and low levels of aldosterone. 
Hypertension is, as elsewhere, a major risk factor for stroke in SSA.72,76,80 Stroke 
caused by hypertension is thus the main reason for mortality and disability in 
SSA.80 Diabetes is equally common in SSA as elsewhere.57,68,75,80,81 Dyslipidemia 
is less common among black South African stroke patients.75,81 Women are more 
commonly obese and men are smoking more.68,82 The other significant risk factors 
in SSA are still prevalent rheumatic heart disease and other infectious diseases, 
poor nutrition and underweight, unsafe water, poor sanitation and hygiene, indoor 
smoke from solid fuels, and deficiencies of zinc, iron, and vitamin A.83 Ischemic heart 
disease and large artery atherosclerosis, like carotid artery disease, are uncommon 
in the black African population though the incidence is expected to increase in the 
future.66,75,80,84  
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2.2.4 HIV and stroke in Sub-Saharan Africa
There were 35.3 million people living with HIV in the world in 2012.56 SSA has 
by far the highest incidence and prevalence of HIV, with every 20th adult living 
with HIV. In SSA, hospital-based studies showed that ischemic stroke is more 
frequent than ICH causing 90% of HIV-associated strokes.76,85,86 In South Africa, 
6% of the admitted stroke patients were HIV-infected.87 Stroke can often be the 
first manifestation of HIV infection in SSA.85
2.2.5 Quality of life after stroke in Sub-Saharan Africa
The quality of life (QOL) research evaluates the general well-being of individuals. 
Acute stroke lowers the QOL when causing to its victims disability and emotional 
stress like depression. In SSA the main research of post-stroke QOL were made 
in Nigeria and Tanzania.88-90 Social and cultural differences are profound between 
the Western countries and SSA, yet in both regions QOL seems to be related with 
disability, depression, and anxiety.
One of the important factors for a stroke patient in the working age is whether 
they are able to return to their work and thus gain long-term economic independence. 
Many SSA countries have inadequate state-provided social security system and 
pension scheme. This makes people with disability very vulnerable. In a Tanzanian 
study, 68% of all-ages stroke patients gave up their work permanently.88 Those 
returning back to work were significantly younger and had better 10-meter walk 
test time than those who were not employed. The post-stroke return-to-work-rates 
vary noticeably in different studies worldwide.91 Typically about half of the patients 
return to work. In recent Japanese research 51% of the working age stroke patients 
returned to work.92 One of the prognostic factors was the walking speed; others were 
no dysphasia, white-collar occupation and no attention dysfunction. 
2.3 INFECTIONS AND ISCHEMIC STROKE
2.3.1 Definitions
Any signs of clinical infection or laboratory findings suggesting infection at stroke 
onset, or reported symptoms within the 4-week period before ischemic stroke define 
preceding acute or chronic infection (PI). Concerning post-stroke period, any acute 
infection occurring during the first few (5-7) days after the onset of stroke, defines 
post-stroke (PSI) or in-hospital infection.
2 Stroke i  Sub-Saharan Africa
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2.3.2 Preceding infections (PI) and ischemic stroke
Chronic infections may increase the risk of stroke through a variety of mechanisms.93 
First, they can influence other risk factors like serum lipids. Infections can be 
a risk factor per se and act together with conventional risk factors and genetic 
predisposition. Second, they can damage vascular endothelium. Third, recurrent 
bacteremia triggers platelet activation and causes a procoagulant state. Chronic 
dental infections are associated with stroke in the young.94,95 Chronic Chlamydia 
pneumoniae-infection and its antibodies are prevalent in both coronary heart disease 
and in young stroke patients.96-98 HIV is discussed below (2.3.5. and 2.5.). Other 
pathogens have not been systematically studied in the young.
Important stroke triggers promoting strokes in patients of any age are acute 
infections, most commonly acute respiratory infection.99-102 Stroke scientists have 
suggested several mechanisms of how infections trigger stroke: elevated antibody 
levels and other manifestations of inflammation reduce the amount of circulating 
antithrombotic proteins. Increased inflammatory markers like CRP, cytokines, 
or interleukins initiate extrinsic coagulation pathway, modulate anticoagulant 
pathway, and increase platelet activity.103 The dysregulation of endothelium 
triggered by infection could initiate a thrombotic process: even minor infection 
can cause endothelial dysfunction in healthy children.104 Contrast-enhanced high 
resolution MRI and positron emission tomography CT have demonstrated a vessel 
wall inflammation in patients with CAD.49 PI is identified to have an association 
with CAD.105 In patients with no other risk factors, acute infections are often 
associated particularly with cardioembolic or large-vessel stroke.106,107 To prevent 
stroke, several methods are investigated: lipid lowering statins also having anti-
inflammatory effects, and influenza vaccine.108,109 
2.3.3 Post-stroke infections (PSI)
PSI is a frequent medical complication during the first few days after the insult in 
all age groups: the two most common types of infection are urinary tract infections 
which occur in 10%-29%, and chest infections in 11%-18% of the cases.110-112 Factors 
like the severity of stroke, increasing age, treatment in intensive care unit, vomiting at 
stroke onset, having dysphagia, or using the nasogastric feeding tube make patients 
prone to infections.112 These PSIs are one of the leading causes of death in stroke 
patients.113-115 
An independent cofactor arousing PSIs is post-stroke immunosuppression. The 
activity of the immune system is modulated by the central nervous system (CNS) 
through pathways including the hypothalamic pituitary adrenal axis (HPAA), the 
vagus nerve, and the sympathetic nervous system.110,114 An alteration of lymphocyte 
homeostasis exists: rapid T-lymphopenia and functional deactivation of T cells is 
a common phenomenon after stroke.116 Sympathetic activity increases after stroke 
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making patients more prone to infections.117 Polish researchers performed an 
interesting trial: they gave β-blockade to patients after stroke and this reduced the 
incidence of pneumonia.118 By reducing sympathetic activity, the immunosuppression 
caused by stroke is reduced. The studies where early antibiotic therapy is given to 
the patient to prevent PSI have failed to show the benefit for the outcome.119,120
2.3.4 Infection parameters and stroke
Inflammatory markers serve as immune system health indicators. Systemic markers 
of inflammation are at the same time risk markers of stroke. During the admission 
of an acute stroke patient these markers are used to analyze and predict the risk of 
PSI. They give clues about the outcome of the stroke patient.121 The used parameters 
should be accurate and easily available. Stroke patients have persistent signs of low-
grade inflammation. It may mirror the ongoing atherosclerotic processes or reflect 
a chronic infectious disease. What needs to be proven is, however, that lowering 
of inflammatory indexes would lower the risk of stroke. In the following, some of 
the parameters are illustrated in greater detail.
In epidemiological studies an independent risk predictor for ischemic stroke 
and myocardial infarction is the increased leukocyte count.43,121,122 It also detects the 
risk of recurrent vascular events.123 Apart from acute or chronic PI, a high leukocyte 
count on admission is related to increased stroke severity and lesion volume, poor 
functional outcome, and an underlying atherosclerosis.124 One of the various types 
of leukocytes, neutrophils, infiltrates the brain within the first 24 hours after acute 
stroke.42,125-127 Neutrophilia associates with the volume of the ischemic lesion. The 
tissue injury in stroke activates microglia within minutes from the onset of ischemia 
and loosens the blood-brain barrier thus allowing macrophages to invade the CNS.42
C-reactive protein (CRP) is, at least in Finland, one of the most commonly used 
laboratory tests in the emergency unit. It is used for the detection of infection 
and inflammation. CRP is a hepatic acute phase protein which circulating levels of 
interleukin-6 (IL-6) are regulating. CRP and especially high-sensitivity CRP (hsCRP) 
are useful risk markers in routine assessment of cardiovascular risk in clinical 
practice. In first-ever ischemic stroke patients the baseline CRP-level detects the 
risk of a new stroke even more effectively than the risk of myocardial infarction.128 
CRP is a nonspecific risk marker predicting mortality in stroke as well as future 
vascular and non-vascular morbidity.128-132 Levels of hsCRP increase with stroke 
severity and may be associated with mortality more than recurrence of stroke.133 
CRP is detected in atherosclerotic plaques.134 It may contribute to atherogenesis 
and the procoagulant state. Statins and aspirin lower CRP-levels and these could 
be tools for anti-inflammatory treatment strategies for stroke patients.135 
Another acute phase reactant at the interface between inflammation and 
coagulation is fibrinogen. Patients with a low plasma fibrinogen level indicate a 
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favorable functional outcome independently of patient’s age, neuroradiological 
findings, or stroke severity.136,137 The raised plasma fibrinogen level lowers with non-
pharmacological treatment, such as cessation of smoking, a healthy diet or exercise.138 
Cytokines are small proteins that are important in cell signaling. Interleukin-6 
is a proinflammatory cytokine that helps to regulate immune reactivity, acute phase 
response, inflammation, oncogenesis, and hematopoiesis.139  It is also synthesized 
for instance in stress, trauma, and tissue injury. After ischemic stroke, IL-6 levels 
are significantly elevated during the first 24 hours.140 It has been used to predict 
the outcome after a stroke.141 
Measurement of copeptin links with a release of vasopressin. This measurement 
detects early myocardial infarction. Procalcitonin (PCT) was first prescribed as a 
precursor for the calcitonin hormone. It is a biomarker that exhibits in greater 
specificity in bacterial infections.142 After infection the PCT response is faster than 
CRP’s, and it is the best parameter for identifying severe infection. In stroke, it 
predicts the risk of post-stroke respiratory tract infection but, however, this marker 
has low sensitivity.143
Among ischemic stroke patients the combination of markers predicted 
the patient’s risk to develop post-stroke pneumonia or urinary tract infection: 
combination of WBC, CRP, and copeptin or procalcitonin measured on admission 
predicted the infection.144 In a study from India: elevated hsCRP and IL-6 in acute 
ischemic stroke patients strongly correlated to functional disability 72 hours after 
the attack.145
2.3.5 HIV infection and stroke
In clinical series, 1-5% of HIV seropositive patients develop stroke. In the USA, 
admissions due to ischemic stroke in HIV patients have increased in nine years by 
46%.146 In another study from USA the incidence of stroke in HIV-infected persons 
was 5.27 per 100 person years compared to incidence rate of in non-infected persons 
3.25 per 100 person years.147 The difference was more significant in younger stroke 
victims and in women. No difference of incidence rates is seen in the hemorrhagic 
stroke ratios.146 Usually stroke patients with HIV are young.86,87,146,147
Both HIV and its therapy increase the risk of ischemic stroke. The possible 
mechanisms of HIV-associated stroke are listed below (Table 2). In USA adults 
living with HIV when compared to general population are more commonly tobacco 
smokers.148 In SSA HIV infection is not more prevalent with tobacco users. The other 
traditional atherosclerotic risk factors have relatively low prevalence in this patient 
group. But inevitably, due to the advent of highly active antiretroviral therapy (cART) 
since the mid-1990s, HIV seropositive people live longer and grow older, and are 
thus exposed to the conventional risk factors.149 This will continue to increase the 
stroke incidence among the HIV seropositive patients. 
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2.4 Functional outcome and mortality of stroke
Table 2. Possible HIV-associated causes of stroke8
Ischemic 
HIV-associated vasculopathy  
 Associated with intracranial or extracranial aneurysm formation
 Vasculitis caused by HIV
 Accelerated atherosclerosis
 Other disease of cerebral blood vessels associated with HIV infection
Opportunistic infection or neoplasia 
 Opportunistic infection causing stroke (tuberculosis, varicella zoster, syphilis)
 Lymphoma
Cardioembolism
 Bacterial endocarditis 
 Marantic endocarditis
 HIV-associated cardiac dysfunction
 Ischemic heart disease
Other causes
 Coagulopathy (antiphospholipid syndrome)
 HIV-associated hyperviscosity
Hemorrhagic
 HIV-associated vasculopathy associated with aneurysm or vasculitis
 HIV-associated thrombocytopenia
 Mycotic aneurysm secondary to bacterial endocarditis
2.4 FUNCTIONAL OUTCOME AND MORTALITY OF STROKE
2.4.1 In young stroke patients with ischemic stroke
The prognosis in the young stroke patient is much better than in the elderly with 
lower mortality, lower recurrence rate, and better functional outcome.24,26,150-156 
However when the stroke patients are compared to their healthy age-mates there 
is at least 10-times higher risk of dying.155-157 The risk of death is highest during the 
first month and the first year after the stroke in the young patients.24,151,152 Usually 
deaths in young adults are caused by recurrent strokes (0%-33%), cardiac causes 
(13%-55%), and malignancies (23%-33%).24,151,155,156,158
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In long-term follow up, from 3 to 12.4 years, most studies describe a favorable 
outcome (mRS=0-2) and independency in 68% - 87% of the young stroke 
patients.22,26,150-152,154,155,157,159 On the other hand 3-5% of the study populations have 
remained with severe disability.151,152 Milder handicap to severe disability is described 
between 14-27% of the patients.155,157 
Of the unmodifiable risk factors, the young stroke patients’ outcome worsened 
with increasing age and for the male sex.154,155 In a Spanish study of the functional 
outcome of ischemic strokes, however, women who were 31-50-year-old had a 
worse functional outcome and higher mortality.160  In a Finnish assessment of 
5-year mortality risk factors, sex did not affect the mortality but the older age of 
more than 45-years increased the risk of death.24 In a Norwegian study of patients 
under 49 years of age, the age did not affect the mortality.156
Short-term mortality in a young stroke population is caused partly by the 
severity of stroke symptoms, when measured with modified National Institutes of 
Health Stroke Scale (NIHSS).22,159,161 In the young, large-artery atherosclerosis was 
strongly associated with high risk of death and stroke of unknown etiology had 
significantly lower mortality.24,151 Stroke caused by cardioembolism increases the risk 
of an unfavorable outcome and death in older stroke patients but among the young 
it was mainly related to short-term mortality after stroke.24 In a Finnish survey, 
internal carotid artery dissection and bilateral ischemic lesions were independent 
predictors of a poor outcome.161 The quality of acute stroke care affects the functional 
outcome of young stroke patients according to two surveys. One compared stroke 
care between Eastern and Western European stroke centers, and the other treatment 
differences between different racial groups in the United States of America.29,162
Diabetes mellitus predicts an unfavorable functional outcome or mortality 
also in the young stroke population.22,24 From cardiovascular causes a worse 
functional outcome or mortality appears especially in heart failure and mitral valve 
stenosis.24,26,158 An unfavorable outcome and mortality are related to risky lifestyle 
of alcoholism or binge drinking.26,156,163 Another life-style risk factor that worsened 
the outcome in a Norwegian study was cigarette smoking.156
Seizures and epilepsy develop in to 6% of the surviving patients usually during 
the first year.152,164 In ICH the risk of developing seizures is even higher: 7% of the 
patients after first year and 11% during five years follow up.65 Epilepsy secondary to 
stroke is an independent factor causing an unfavorable outcome in the young.156,165
Stroke recurrence was at its highest during the first year: 1-4% of the patients 
and continues in a rate of 1% per year during the longer term follow-up reaching 
as high as 9% during a 6-years follow-up.150-152
Despite the fact that most stroke patients who are in working age, recover to be 
independent after stroke, only half of them (42%-69%) return back to work.151,153,155,166 
In recently published long-term follow up one young stroke patient out of eight 
surviving patients is not able to live independently even after 10 years from stroke.167
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2.4 Functional outcome and mortality of stroke
2.4.2 In Sub-Saharan Africa
The 7th most common cause of disability-adjusted life years (DALY) in southern 
SSA in 2010 were cerebrovascular diseases.168 In SSA, only usually the most severe 
cases of stroke patients present to the hospital and are included to hospital-based 
studies. In Gambia, only eight stroke-patients out of 130 made a complete recovery 
during a one-year follow-up.73 The functional outcome is rarely assessed in SSA 
stroke studies.
In many countries of SSA, death certificate data are often unavailable and 
vital registration systems are lacking, incomplete, or unreliable. Despite these 
difficulties, the Global Burden of Disease investigators estimated that in Africa, 
during 2004, occurred 424 673 stroke deaths (4% of all 11 200 000 deaths).169,170 
This estimation was based on the continent’s existing records, census and survey 
models, and population-based epidemiological studies. From 1990-2010 in all SSA 
countries independently of whether they were rated as high, middle or low-income, 
the mortality-rates of stroke decreased significantly.171 Cerebrovascular diseases as 
the leading cause of years of life lost in southern SSA in 2010 ranked 7th.172 Verbal 
autopsy (VA) is a method of determining individuals’ causes of death in populations 
coming from resource-poor settings with nonexistent vital registration system.173 
VA consists of an interviewer with a questionnaire, who interviews a person who 
knew the recently deceased person. Using the questionnaire the recent symptoms, 
signs, and characteristics of the deceased are collected to determine the cause of 
death. VA provides the only detailed mortality data for most SSA.53 In the Tanzanian 
study where the mortality rate for both rural and urban area was estimated with VA, 
stroke was a cause of death in 6% of all deaths of the urban and rural regions.174 In 
another VA-based study from rural RSA, 6% of all deaths were caused by stroke.175 
In a more recent Tanzanian study of 130 stroke patients, 24% died during the first 
month after the stroke and 60% during the 3-year follow up.176 Older age and history 
of smoking were the only pre-stroke risk factors for case-fatality in this study. In 
a Gambian study, the mortality rates in one month and after a four-year follow-
up were respectively 27% and 75%.73 In this study, the initial stroke was the cause 
of death in 61% of the deaths. Unlike in high-income countries, where the post-
stroke cardiovascular complications are relatively common, only one patient died 
of cardiomyopathy and none of myocardial infarction. In another Gambian study 
in-hospital and one year mortality rates were higher: 41% and 62% respectively.71 In 
a recent Nigerian study of an urban population the one month case fatality rate was 
only 17%.65 Overall, case fatality of stroke in Africa when estimated from hospital-
based prospective studies, is about 30% during the first month post stroke, which is 
higher than the average 23% in much older populations in the rest of the world.69,177
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2.4.3 In HIV patients
HIV seropositive young people, when compared to their HIV seronegative age-
mates, are at higher risk of developing ischemic stroke.85,147,178 In post-stroke HIV 
seropositive homosexual men the recurrence of stroke was higher than in HIV 
seronegative stroke victims.179 HIV-related stroke patients’ functional outcome and 
mortality needs a good clinical assessment. 
2.5 LONG-TERM EFFECTS OF HIV INFECTION IN BRAIN
Before the development of combined antiretroviral therapy (cART) for HIV 
infection, it commonly caused severe cognitive disorders.180-182 This wide range of 
neurocognitive complications fall under the acronym of HANDs (HIV-associated 
neurocognitive disorders).183 This group of disorders is further divided into 
asymptomatic neurocognitive impairment, mild neurocognitive disorder, and 
HIV-associated dementia (HAD).  HAD associates with HIV-infection in the AIDS 
phase. Before the era of cART, the characteristics of HAD were the same as in sub-
cortical dementia with notable clumsiness in motor function, behavioral changes, 
and loss of attention and concentration.184 Since the start of the use of cART in 
high-income countries after 1996, HIV neurocognitive manifestations have changed, 
HAD has become rare. Even patients with long compliance and good response to 
cART can, however, suffer from HAND in milder forms.184,185 About half of the 
patients on cART, continue to show performance levels lower than expected.186 The 
characteristic HAND symptoms are less frequently subcortical. This clinical picture 
includes impairment in learning, in prospective memory, and in executive function; 
the pattern resembles neurodegenerative disorders like Alzheimer’s disease.181,185,187 
The challenge is to differentiate these diseases in the aging brain.
The scientific community has suggested multiple possibilities for the causes 
of continuing high HANDs prevalence.8,185,188 First, before the initiation of cART 
irreversible brain injury has developed already. Second, cART-treated individuals 
continue to show in the CNS HIV replication at low levels. This prolonged CNS 
inflammatory responses and neurotoxic viral proteins may result in neural injury 
or dysfunction; Prolonged CNS inflammatory responses are implicated in HAND 
pathogenesis. Third, development of HAND is linked to the history of low nadir CD4 
(< 200 cells/mm3). Fourth, some studies have suggested that better neurocognitive 
outcome corresponds to CNS-penetrating cART-regimes. Other studies, however, 
conflict with these; thus the role of these regimes is still controversial.189 All cART-
regimes benefit the brain by multiple mechanisms both systematically and in the 
CNS. Finally HIV patients may become exposed to other conditions that may affect 
cognition in long-term survivors, such as metabolic abnormality and associated 
vascular pathology or increased B-amyloid deposition in the brain. 
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2.5 Long-term effects of hiv infection in brain
3 AIMS OF THE STUDY
1. To investigate the factors associated with high leukocyte count and to its impact 
on short- and long-term functional outcome in young patients with first-ever 
ischemic stroke (I).
2. To study the effect of both preceding and post-stroke infections to the outcome 
in young patients with first-ever ischemic stroke (II). 
3. To define the characteristics and the one year outcome of first-ever ischemic 
or hemorrhagic stroke, and the impact of the HIV epidemic on the stroke 
outcome in the Sub-Saharan country of Malawi (III).
4. To study the impact of stroke on the life situation and quality of life in post-
stroke patients in Malawi (IV).
5. To learn how the HIV affects the long-term functional and cognitive status of 
HIV-infected receiving the best available treatment and care (V).
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4 PATIENTS AND METHODS
The study consists of three parts: the first two publications, I and II, were carried 
out at the Department of Neurology, Helsinki University Central Hospital (HUCH), 
Helsinki, Finland, during the years 2011-2013. Publications III and IV are based on 
a research in the Medical Department, College of Medicine, University of Malawi, 
Blantyre, Malawi, during the years 2007-2010. The last work (V) was undertaken 
at the Department of Infectious Diseases, HUCH Aurora Hospital in the years 
2013-2014. All the study protocols and procedures were approved by relevant local 
authorities in both participating centers, Helsinki and Blantyre. 
4.1 DATA COLLECTION
4.1.1 Finnish young stroke patients (I, II)
HUCH serves as the only neurological emergency unit for patients who are 
independent in daily living. The catchment area population is 1.5 million. The 
Helsinki Young Stroke Registry (HYSR) includes all 15- to 49-year-old patients 
with first-ever ischemic stroke treated in HUCH between January 1994 and May 
2007.13 This registry defines ischemic stroke as an episode of focal neurological 
deficits with acute onset and lasting more than 24 hours, or lasting less than 24 
hours with imaging evidence of an acute ischemic lesion. Patients were identified 
from the prospective discharge database of the hospital. Patients living in the defined 
hospital catchment area, and having discharge diagnosis of an ischemic stroke were 
included in the registry.
Our studies I and II are retrospective, observational, and based on the HYSR. 
The following stroke risk factors were recorded in both studies: hypertension, 
hypercholesterolemia, high fasting blood sugar and diabetes, smoking (≥1 
cigarette a day), excessive drinking of alcohol (more than 200 g per week of pure 
alcohol), cardiovascular disease (coronary heart disease, heart failure, myocardial 
infarction, or peripheral arterial disease), and obesity (Body mass index ≥ 30 kg/m2). 
Hypertension was defined as repeated blood pressure measurements of ≥140/90 
mmHg.190 Patients who were medicated for hypertension or who had a history of 
hypertension were defined as hypertensive. Hypercholesterolemia was defined as 
treated or total cholesterol level ≥5.0 mmol/L, low-density lipoprotein level ≥3.0 
mmol/L, or high-density lipoprotein level <1.0 mmol/L (39 mg/dL). According 
to the WHO criteria, fasting blood sugar level of ≥7.0 mmol/L was considered 
high. Patients treated for diabetes and those who fulfilled the WHO criteria were 
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4.1 Data collection
considered diabetic.191 Stroke mimics and those who were lost to follow-up were 
excluded from our studies. TOAST was used for ischemic stroke subtyping.4 Ischemic 
lesion size was estimated from the CT or MRI scan according to the largest lesion.192 
We used documented criteria, and categorized the lesions in to small, medium, or 
large and, if the lesion was situated in the territory of more than one main cerebral 
arteries, multiterritorial.
For the first publication (I) we reviewed the medical and laboratory data of all 
patients. The leukocyte count was measured from the blood sample drawn at hospital 
admission and analyzed in a central laboratory. We excluded patients who did not 
have this leukocyte count measured within the first two days from the onset of index 
stroke. Patients, whose count was less than 3.5 x 109 cells/L or exceeded 25.0 x 109 
cells/L (outliers), were excluded to allow comparability with earlier studies.123 We 
also divided the leukocytes into four quartiles: 1st quartile, <5.86 x 109 cells/L; 2nd 
quartile, 5.86 to 6.91 x 109 cells/L; 3rd quartile, 6.92 to 8.22 x 109 cells/L; and 4th 
quartile, >8.22 x 109 cells/L.  
We analyzed the admission C-reactive protein (CRP) level and aural temperature 
(I). The laboratory reference for normal CRP was <5 mg/L during the study period. 
Fever was defined as aural temperature ≥38ºC in both (I and II) publications.
For the second publication (II) we reviewed all the patient files with medical 
data and laboratory results. Preceding infection (PI) included any signs of clinical 
infection or indicative laboratory data at stroke onset, or reported symptoms of any 
infectious disease within the four-week period prior to index stroke. Post-stroke 
infection (PSI) included any acute infection occurring within seven days of stroke 
onset. These infections were further identified according to their site and character 
to the following groups: 1) Severe infections, including sepsis and endocarditis; (2) 
Chest infections, including pneumonia and pleuritis; (3) Upper respiratory tract 
infections including flu-like symptoms, sinusitis, bronchitis, and otitis media; 
(4) Genitourinary infections including urinary tract infections, pyelonephritis, 
and endometritis; (5) Gastrointestinal infections; (6) Skin and mucous infections 
including infections caused by foreign objects like iv-line, dermatitis, and otitis 
externa; and (7) Chronic PI, such as periodontitis or HIV infection.  This study 
included those with multiple infections in different focuses or with both PI and PSI. 
Our study excluded as infections those with fever only or who were treated with 
a course of antibiotics, but did not have any clinical signs of infection. The study 
analyzed following inflammatory parameters; admission and the highest values of 
CRP, leukocyte count, and aural temperature.
The patients were followed up for three months. A structured interview of the 
patient, their next of kin, or carer was carried through by telephone for the long-
term follow-up. The mean follow-up period was 8.1 ± 4.2 years in study I, and 7.8 






























Figure 5. Flow chart for Finnish patients (I, II) 
4.1.2. Malawian stroke patients (III, IV) 
 
Our study took place in Queen Elizabeth Central Hospital (QECH) which is the biggest hospital in 
Malawi. Being the only public hospital for Blantyre region it is responsible for care from health 
center based care to the hospital-level. QECH also admits referred patients from other areas of 
Malawi. It is situated next to the University of Malawi, College of Medicine. It is a teaching 
hospital for clinical training of medical students. The population of the Blantyre-district is 1.5 
million inhabitants.193 Our study, the stroke outcome in Malawi (SOMA), was a prospective and 
observational study. The WHO definition of stroke was used: “rapidly developing clinical signs of 
focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer or 
leading to death, with no apparent cause other than of vascular origin.”2 This study included 
patients fulfilling the WHO definition, living within the defined catchment area, arriving at the 
hospital within a week of their stroke symptom onset, and giving consent (the patient or a next of 
kin in case the patient was unable to). TIA-patients and patients with clinical signs of subarachnoid 
hemorrhage, trauma causing stroke, non-vascular cause for the stroke-like symptoms, or any 
concomitant severe disease were excluded from the study. 
Helsinki Young Stroke Registry from 1994 to 
2007: 1008 ischemic stroke patients aged 15-
49 years. 
781 patients (mean age 41.4±7.6 years) 
included (study I). 
681 patients (mean age 44) included 
(study II). 
205 patients without leukocyte 
count result within days 0-2. 
231 patients excluded in baseline 
assessment (may overlap): 189 
admission > 2 days from stroke onset, 
23 in-hospital stroke, 43 only 
outpatients, 48 unknown stroke onset. 
6 patients leukocyte count was 
below 3.5 x 109 cells/L or 
above 25 x 109 cells/L.
16 patients excluded 
during the follow-up: 4 
refused, 7 lost to follow-
up, 3 stroke mimics, 2 
missing 3-month mRS. 
69 no inflammatory data or 
aural temperature not measured 
within days 0-2. 
27 patients excluded 
during the follow-up: 5 
refused, 7 lost to follow-
up, 2 missing 3-month 
mRS, 13 malignancy. 
Figure 5. Flow chart for Finnish patients (I, II)
4.1.2 Malawian stroke patients (III, IV)
Our tudy to k place in Queen Elizabeth Central Hospit l (QECH) which is the 
biggest hospital in Malawi. Being the only public hospital for Blantyre region it 
is responsible for care from health center based care to the hospital-level. QECH 
also admi s referred patients from o her areas of M lawi. It is situated next to 
the University of Malawi, College of Medicine. It is a teaching hospital for clinical 
training of medical students. The population of the Blantyre-district is 1.5 million 
inhab ants.193 Our s udy, he stroke utcome in Malawi (SOMA), was a prospective 
and observational study. The WHO definition of stroke was used: “rapidly 
developing clinical signs of focal (or global) disturbance of cerebral function, with 
symptoms lasting 24 hours or longer or leading to death, with no apparent cause 
other than of vascular origin.”2 This study included patients fulfilling the WHO 
definition, living within the defined catchment area, arriving at the hospital within 
a week of their stroke symptom onset, and giving consent (the patient or a next 
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4.1 Data collection
of kin in case the patient was unable to). TIA-patients and patients with clinical 
signs of subarachnoid hemorrhage, trauma causing stroke, non-vascular cause 




Our study patients were mainly recruited from the admission and medical wards of QECH. The 
admission ward is an on-call ward, where to patients are referred from the outpatient clinics, stay 
for a short-term, usually less than 24 hours, and are then admitted to the hospital or discharged. 
Using the information from the patient, their guardian, and patient’s hand-held medical record as 
well as clinical observation and laboratory investigations, the following conventional risk factors 
were recorded: hypertension, hypercholesterolemia, and diabetes which were defined according to 
the WHO criteria as above. Obesity and nutrition were estimated using the mid upper arm 
circumference (MUAC). The nutritional status was estimated by measuring MUAC. The reference 
rate for adults is from 23 cm to 33 cm indicating normal nutritional values.82 Other life style risk 
factors were recorded: smoking (> one cigarette a day) and excessive drinking of alcohol (estimated 
more than 100 g alcohol a day, this definition is different from the Finnish studies I and II)). When 
available, we carried out CT or MRI of the brain. Most of the patients agreed with HIV-testing. The 
type of stroke was classified according to the Bamford criteria.194 The patients were re-evaluated on 
the ward, at the outpatient clinic, or at their home six months and one year later. We conducted a 
telephone call for those who moved away or could not be reached physically. 
In manuscript IV, patients recruited for SOMA and followed up for more than six months, were 
included. They were interviewed using a structured form (NEWSQOL, see below) for QOL 
asse sment. We further asked questions about their post-stroke employment and accommodation. 
Due to its interview-based character, this study excluded those with severe dysphasia or who were 




















3 patients with brain 
tumor. 
147 patients 
remained in  
SOMA.(III) 
During the first six 
months  
52 patients died  
14 absconded.  
81 patients were 
analyzed for 
quality of life.(IV) 
25 patients were 
interviewed with 
NEWSQOL.(IV) 
27 patients with dysphasia or very 
severe stroke,  
15 patients followed by phone 
contact, only. 
14 patients no interview due to 
language barrier. 
Figure 6. Flow chart of the Malawi patients (III, IV)
Our study patients were mainly recruited from the admission and medical wards 
of QECH. The admission ward is an on-call ward, where to patients are referred 
from the outpatient clinics, stay for a short-term, usually less than 24 hours, and are 
then admitted to the hospital or discharged. Using the information from the patient, 
their guardian, and patient’s hand-held medical record as well as clinical observation 
and laboratory investigations, the following conventional risk factors were recorded: 
hypertension, hypercholesterolemia, and diabetes which were defined according 
to the WHO criteria as above. Obesity and nutrition were estimated using the 
mid upper arm circumference (MUAC). The nutritional status was estimated by 
measuring MUAC. The reference rate for adults is from 23 cm to 33 cm indicating 
normal nutritional values.82 Other life style risk factors were recorded: smoking 
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(>one cigarette a day) and excessive drinking of alcohol (estimated more than 100 
g alcohol a day, this definition is different from the Finnish studies I and II)). When 
available, we carried out CT or MRI of the brain. Most of the patients agreed with 
HIV-testing. The type of stroke was classified according to the Bamford criteria.194 
The patients were re-evaluated on the ward, at the outpatient clinic, or at their 
home six months and one year later. We conducted a telephone call for those who 
moved away or could not be reached physically.
In manuscript IV, patients recruited for SOMA and followed up for more than six 
months, were included. They were interviewed using a structured form (NEWSQOL, 
see below) for QOL assessment. We further asked questions about their post-stroke 
employment and accommodation. Due to its interview-based character, this study 
excluded those with severe dysphasia or who were still very ill. The interview was 
conducted either in English or in local language Chichewa.
4.1.3 Finnish HIV-seropositive patients (V) 
This is an interventional follow-up study. We wanted to compare the changes 
in neurological and neurocognitive functions at least 25 years after onset of the 
infection. All patients had the HIV-1-type of infection. HIV seropositive patients 
were first recruited to this study between 1986 and 1990.195-197 These all male HIV-
infected patients have been treated and followed in the Aurora Hospital since the 
start of the HIV recognition in 1980. Aurora hospital is specialized in infectious 
diseases. HIV infection and AIDS are reportable diseases in Finland. Antiretroviral 
treatment is free for the patient. Altogether in year 1991, there were 248 patients 
with diagnosis of HIV attending the HIV clinic in Aurora. This made up two thirds 
of the HIV patients in Finland. In 1996 cART became available in Finland. In 1997 
the surviving study population was re-examined.198 In this follow-up the cognitive 
decline was relatively mild but brain atrophy had increased in the MRI analysis.199 
At present this cohort of HIV patients have lived with the disease for more than two 
decades. We included all HIV seropositive study subjects from the original cohort 
who were examined both in 1986-1990 and 1997, and who were willing to participate 
and signed the informed consent for the study. During the very first recruitment 
those patients were excluded, who had a history of CNS-disease or present HIV-
related CNS-disease, if they had a marked learning disability, or prominent alcohol 
consumption.
Our study contained the neurological examination, neuropsychological 
investigation, laboratory tests, and MRI of the brain as the radiological investigation. 
The study registered from the patient’s medical records and through conducting 
an interview, the level of education, and past and present employment. A detailed 
HIV history was taken and included: the estimated date of acquisition and date 
of diagnosis, the risk behavior group, history of antiretroviral therapy, CD4 count 
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4.1 Data collection
at the time of diagnosis, nadir CD4, and HIV RNA. We analyzed all AIDS events, 
antiretroviral medication, the start of cART, and possible pauses of the use of cART. 
Our patients were further divided in groups depending if they had been in cART 
for more than 10 years or not and whether they had had a low nadir CD4 ( <200 
cells/mm3) or not.
The study recorded from other medical history, cardiovascular diseases and 
events, metabolic diseases, psychiatric diagnoses, substance use (including alcohol 
and smoking), and medication. Patients completed a form of fatigue severity scale 
(FSS) to estimate the level of fatigue experienced (see 4.2.5).200 The form was 
translated in to Finnish (Appendix 2).
For estimation of the nutrition we calculated the body mass index. Regarding 
the neurological examination of the patient, we tried to standardize the results with 
the use of neurostatus and EDSS (see 4.2.4).201 
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HCVAb, HCVRNA for HCVAb seropositives), syphilis serology from blood, electrocardiogram, 
plasma serum samples for possible neurological, metabolic and inflammation marker studies, 
plasma HIV-1 RNA, and bl od CD4 count.  
The brain MRI was performed on a 3.0 Tesla (T) MR unit (Philips, Achieva). The MRI protocol 
included conventional T2, FLAIR, T2*, DWI axial, T2 coronal, and T1 MPR sagittal images. The 
images were compared to the 1.5 T MRI pictures from 1997. The vascular degeneration was 
stimated using the Fazekas scale, where 0 denotes no signs of degeneration, 1=mild, 2=moderate, 


















Figure 8. Flow chart of the follow-up study of Finnish HIV seropositive patients (V). 
 
4.2. Outcome predictors and methods 
4.2.1. Acute stroke severity: NIHSS and mNIHSS (I-IV) 
 
The NIHSS is widely used in the western world to estimate the severity of acute stroke.209 It is 
composed of 11 items, each of which gives 0-4 points. 0 score means no symptoms in that item and 
17 patients were 
included year 2013. 
106 patients 
were screened 
26 patients were 
excluded. 
80 patients were 
included years 
1986-1990. 
23 patients were 
included year 1997. 
47 patients died, most with AIDS-
related causes. 
7 absconded 
3 refused for the follow-up. 
6 patients died: 2 AIDS-related 
and 4 with non-AIDS-related 
causes. 
Figure 8. Flow chart of the follow-up study of Finnish HIV seropositive patients (V).
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The neuropsychological examination included measures of mental flexibility 
(Wechsler adult intelligence scale WAIS/Digit Symbol; Trail-Making B),202,203 
memory (Wechsler memory scale WMS/Logical Memory I, II and Associative 
Learning ; List learning task; Complex Figure/retrieval),204,205 language and related 
skills (WAIS/Arithmetic and Similarities),  visual-spatial skills (WAIS-R/Picture 
Completion and Block Design ; Complex Figure/copying), motor skills (Tapping).206 
The mental state was evaluated using the Beck Depression Inventory/Short Form.207
Turning to laboratory assessment the following tests were obtained: a 
complete blood count, liver function (aspartate aminotransferase [AST], alanine 
aminotransferase [ALT], alkaline phosphatase, total bilirubin), kidney function 
(creatinine, protein in urine), plasma glucose, serum sample plasma lipids 
(cholesterol [total, HDL, LDL] and triglycerides), viral hepatitis serology (HBsAg, 
HBcAb, HCVAb, HCVRNA for HCVAb seropositives), syphilis serology from blood, 
electrocardiogram, plasma serum samples for possible neurological, metabolic and 
inflammation marker studies, plasma HIV-1 RNA, and blood CD4 count. 
The brain MRI was performed on a 3.0 Tesla (T) MR unit (Philips, Achieva). 
The MRI protocol included conventional T2, FLAIR, T2*, DWI axial, T2 coronal, 
and T1 MPR sagittal images. The images were compared to the 1.5 T MRI pictures 
from 1997. The vascular degeneration was estimated using the Fazekas scale, where 
0 denotes no signs of degeneration, 1=mild, 2=moderate, and 3 indicates severe 
vascular degeneration.208
4.2 OUTCOME PREDICTORS AND METHODS
4.2.1 Acute stroke severity: NIHSS and mNIHSS (I-IV)
The NIHSS is widely used in the western world to estimate the severity of acute 
stroke.209 It is composed of 11 items, each of which gives 0-4 points. 0 score means 
no symptoms in that item and 4 means the most severe symptoms. In publications 
I and II, we considered the stroke-induced impairment assessed by NIHSS in the 
following way: 0-6 points categorized as mild, 7-14 as moderate, or ≥15 as severe 
impairment.
The NIHSS was adjusted for the SOMA (III, IV), because many Malawian 
patients do not know their age, which was asked in one of the items. The question 
of age we replaced by asking the name of the current president of Malawi (mNIHSS). 
Stroke symptoms were categorized as follows: mNIHSS 0-6 as mild, 7-12 moderate, 
13-20 severe, and ≥ 21 very severe stroke symptoms.
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4.2.2 Functional outcome: mRS (I- IV)
The mRS measures the degree of disability or independence in daily activities 
(table 3).5 It is widely used for estimating the functional outcome after stroke. The 
bigger the mRS value the greater the dependency and disability. The scale is best 
assessed face to face, but can be assessed based on patient self-reporting as well 
as via telephone. In our studies I and II the mRS was categorized into two groups: 
mRS 0-1 indicating a favorable outcome and mRS 2-6 an unfavorable outcome. In 
our studies in Malawi (III, IV) the mRS was divided in three different categories, 
where mRS 0-2 was considered a good outcome in which patients were independent, 
mRS 3 was considered a fair outcome, where patients needed a little help, and mRS 
4-6 was considered a poor functional outcome.
Table 3. Interpretation of the modified Rankin Scale.6
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4 means the most severe symptoms. In publications I and II, we considered the stroke-induced 
impairment assessed by NIHSS in the following way: 0-6 points categorized as mild, 7-14 as 
moderate, or ≥15 as severe impairment. 
The NIHSS was adjusted for the SOMA (III, IV), because many Malawian patients do not know 
their age, which was asked in one of the items. The question of age we replaced by asking the name 
of the current president of Malawi (mNIHSS). Stroke symptoms were categorized as follows: 
mNIHSS 0-6 as mild, 7-12 moderate, 13-20 severe, and ≥ 21 very severe stroke symptoms. 
4.2.2. Functional outcome: mRS (I- IV) 
The mRS measures the degree of disability or independence in daily activities (table 3).5 It is widely 
used for estimating the functional outcome after stroke. The bigger the mRS value the greater the 
dependency and disability. The scale is best assessed face to face, but can e assessed based on 
patient self-reporting as well as via telephone. In our studies I and II the mRS was categorized into 
two groups: mRS 0-1 indicating a favorable outcome and mRS 2-6 an unfavorable outcome. In our 
studies in Malawi (III, IV) the mRS was divided in three different categories, where mRS 0-2 was 
considered a good outcome in which patients w re independ nt, mRS 3 was considered a fair 
outcome, where patients needed a little help, and mRS 4-6 was considered a poor functional 
outcome. 
able 3. Interpretati n of the modified Rankin Scale.6 
Score Interpretation 
0 No symptoms 
1 No significant disability. Able to carry out all usual activities, despite some symptoms 
2 Slight disability. Able to look after own affairs without assistance, but unable to carry 
out all previous activities 
3 Moderate disability. Requires some help, but able to walk unassisted 
4 Moderately severe disability. Unable to attend to own bodily needs without assistance, 
and unable to walk unassisted 
5 Severe disability. Requires constant nursing care and attention, bedridden, incontinent 
6 Dead 
4.2.3. Quality of life: NEWSQOL (IV) 
NEWSQOL interview is composed of 11 domains and altogether 56 questions.210 The domains are: 
Feelings, ADL/self-care, cognition, mobility, emotion, sleep, interpersonal relationships, 
communication, pain/sensation, vision, and fatigue (see Appendix 1). Every question or item has 
four options for a response. After a specific calculation every item gives a score ranging from 0 
(worst QoL) to 100 (best QoL). NEWSQOL was translated into the local language, Chichewa. 
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4.2.3 Quality of life: NEWSQOL (IV)
NEWSQOL interview is composed of 11 domains and altogether 56 questions.210 
The domains are: Feelings, ADL/self-care, cognition, mobility, emotion, sleep, 
inte personal relationships, communication, pain/se sa ion, visio , and fatigue 
(see Appendix 1). Every question or item has four options for a response. After a 
specific calculation every item gives a score ranging from 0 (worst QoL) to 100 (best 
QoL). NEWSQOL was translated into the local language, Chichewa.
4.2.4 Neurostatus and EDSS (V)
The functional status scale (neurostatus) and EDSS were developed to provide a 
standardized measure for global neurological impairment.201 These are mainly used 
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when evaluating the impairment caused by multiple sclerosis. The neurostatus 
include functional systems (FS) of pyramidal, cerebellar, brainstem, sensory, bowel 
and bladder, visual, and cerebral (or mental). In our study we excluded cerebral 
domain because of the extensive neuropsychological examination where mental state 
was evaluated with Beck Depression Inventory.207 Based on a standard neurological 
examination, the neurostatus rates the FSs as following: 0-1 means no symptoms, 
signs only, 2 mild symptoms and signs, 3 moderate symptoms and signs, and 4-6 
severe symptoms and signs. The FS domains are used to determine patients EDSS 
together with patient’s ability to walk (ambulatory). The clinical meaning of EDSS 
score is: 0-2.5 points means no or minimal disability, 3-3.5 moderate disability, 
4-4.5 relatively severe disability but fully ambulatory, 5-5.5 severe disability and 
ambulatory 100-200 meters. 7-7.5 needs assistance for walking, 8-8.5 in wheelchair 
or bedridden but retains some self-care, 9-9.5 helpless and bedridden, and 10 
meaning death.
4.2.5 Fatigue severity scale (V)
Fatigue is a prominent disabling symptom in a variety of neurological and medical 
disorders.200 Fatigue severity scale (FSS) was developed to evaluate tiredness in 
chronic conditions (see Appendix 2). It measures of the disabling fatigue on daily 
functioning. FSS is a short questionnaire with nine statements, where the patient 
circles a number between 1 to 7, depending on how strongly he/she agrees with 
the statement. A high value indicates strong agreement and a low value strong 
disagreement to the statement. A total score of more than 36 (maximum 63 in 
most severe fatigue) suggests fatigue.
4.3 STATISTICAL METHODS
4.3.1 Studies I and II
We tested normality of continuous variables. The studies compared categorical 
variables with Chi-square and Fisher’s exact tests. They compared normally 
distributed variables with Student’s T-test and ANOVA. Furthermore, we used 
for non-normally distributed continuous variables Mann-Whitney U and Kruskal-
Wallis tests. The binary logistic regression analysis was used to identify factors 
associated with an unfavorable 3-month outcome. After exclusion of patients who 
died within 30 days of the index stroke, a Cox proportional hazard model was 
constructed and adjusted for age and gender, and covariates known to associate 
with higher mortality in this patient population (age, gender, dyslipidemia, smoking, 
hypertension, cardiovascular disease, type 1 and type 2 diabetes, heavy drinking, 
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stroke severity and etiology, and lesion size). Proportionality assumptions for the 
Cox model were checked and no violations occurred. Two-sided significance was set 
at P<0.05. The statistical analyses were conducted using SPSS 19.0 for Macintosh. 
For study I: the leukocyte count was analyzed both as a continuous variable and 
in quartiles. CRP was analyzed as a dichotomized variable: <5 and ≥5 mg/L. Multiple 
linear regression with forward stepwise entry was used for exploratory analysis on the 
baseline variables correlated with leukocyte count. In addition to age, gender, delay 
to leukocyte measurement, and all variables independently associated with higher 
leukocyte count, the adjustment in that analysis was based on univariate comparison 
between patients with favorable and unfavorable outcome with a criterion of 
P<0.05. The Kaplan-Meier log rank test served as the univariate analysis of the 
effect of baseline factors on the risk for endpoint events. Variables associated with 
a higher leukocyte count were additionally included in these models. Furthermore, 
to better rule out possible infection that may have emerged between stroke onset 
and admission, outcome analyses were subsequently adjusted for admission body 
temperature and CRP. Finally, we performed a sensitivity analysis on the main 
outcome interests by including only patients with leukocyte measurement on day 0. 
For the study II: The model adopted to assess the 3-month outcome was adjusted 
for age and gender, and variables known to correlate with unfavorable outcome 
in this patient population in a univariate analysis (dyslipidemia, heart failure, 
peripheral arterial disease, smoking, heavy drinking, admission NIHSS score, 
etiology lesion size, lesion in multiple territories). Furthermore, the model was 
adjusted for the recorded inflammatory parameters, including the highest values 
of body temperature, leukocyte count, and CRP. PSI was included in the model 
investigating the effect of PI and vice versa. The Kaplan-Meier log rank test served 
for univariate analysis of the effect of preceding and in-hospital infections on the 
risk of long-term endpoint events. Since mortality was the only long-term outcome, 
in which there was a significant difference between the groups with or without PI 
and with or without PSI, only that endpoint was analyzed in a multivariate model. 
This model also included the same inflammatory parameters mentioned above. 
4.3.2 Studies III and IV
Data were analyzed using the Statview™ and STATA™ for multivariate analysis. 
Descriptive statistics (mean, SD) were used to describe the baseline data. Standard 
error of the mean (SEM) was used instead of SD in study IV because of the small 
sample size. Proportions were compared by χ2 test and means by Student’s t-test 
for normally distributed data, and the Kruskal-Wallis test for non-parametric data. 
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4.3.3 Study V
The neuropsychological parameters were analyzed using the parametric and non-
parametric tests. The SPSS statistical software package was used for statistical 
analysis. Neuropsychological data were analyzed with multivariate analyses of 
variance (Manovas) and subsequent Anovas. The effect of age was controlled by 





5.1 FUNCTIONAL RECOVERY AND MORTALITY  
 IN FINNISH YOUNG STROKE PATIENTS
The HYSR includes 1008 patients aged 15-49 years who experienced their first-ever 
ischemic stroke between January 1994 and May 2007. Out of the total number, 781 
patients fulfilled our inclusion criteria for publication I. For study II, 681 patients 
from the HYSR fulfilled the inclusion criteria. Their mean age was 41.4 ± 7.6 years 
in both studies. In both studies, the male gender was more common: 62%.
5.1.1 Effects of leukocytosis (I)
Most of the stroke patients (75%) had their leukocyte count measured on the same 
day (day 0) of the stroke symptom onset. Patients with severe stroke symptoms 
(NIHSS≥15) sought medical help and were admitted earlier than patients with 
milder symptoms (Kruskal-Wallis P<0.001). The mean leukocyte count (8.9 ± 3.1 
x 109 cells/L) was greater than the laboratory reference value (3.4 to 8.2 x 109 
cells/L). The leukocyte count tended to decrease in patients who had delay in seeking 
treatment, but this trend was non-significant (ANOVA P=0.229).
Age and gender did not correlate with the leukocyte count. In exploratory 
multiple linear regression, the higher leukocyte count related to the higher NIHSS 
score (per point increase 95% CI 0.02-0.10, p=0.003), larger lesion size (95% CI 
0.21-0.62, p<0.001), presence of multiterritorial lesions (95% CI 0.52-2.42, p=0.03), 
dyslipidemia (95% CI 0.04-0.89, p=0.031), cigarette smoking (95% CI 0.37-1.21, 
p<0.001), and peripheral arterial disease (95% CI 0.45-3.56, p=0.012).
An unfavorable 3-month outcome, mRS 2-6, was associated with older age 
(40.4 years versus 42.4 years, p=0.004). Other risk factors that were related with 
an unfavorable outcome in the univariate analysis were: preceding infection, 
heart failure, malignancy, and heavy alcohol drinking. Regarding stroke features, 
the following were correlating with an unfavorable outcome: severity of stroke 
(p<0.001), larger lesion size (p<0.001), and multiterritorial lesions (p<0.001). 
Patients with the following conditions had unfavorable outcomes: stroke etiology 
of large-artery atherosclerosis, high-risk source cardioembolism, or internal carotid 
artery dissection.
An unfavorable outcome (p<0.001) at three months was associated with a CRP ≥ 
5. The higher aural temperature on admission did not affect the outcome (p=0.063). 
The leukocyte count was divided in to four quartiles: 1st quartile, <5.86 x 109 cells/L; 
2nd quartile, 5.86 to 6.91 x 109 cells/L; 3rd quartile, 6.92 to 8.22 x 109 cells/L; and 
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4th quartile, >8.22 x 109 cells/L. A very unfavorable outcome (mRS 3 to 6) was 
strongly associated with the highest leukocyte count quartile. When CRP and body 
temperature were added in the analysis of outcome, the leukocyte count remained a 
significant predictor (odds ratio 1.12 per unit increment, 95% CI 1.04-1.12, P=0.003). 
Also, after a multifactorial analysis, in which demographics, risk factors, stroke 
severity and subtype, lesion size, presence of multiterritorial lesions, and delay to 
leukocyte measurement were included, the 3-month unfavorable outcomes were 
associated with the highest quartile of leukocyte count, when compared to the lowest 
quartile (OR 2.32 for 4th versus 1st quartile, 95% CI 1.32-4.09, P=0.003).
A high leukocyte count on admission did not correlate with long-term (8.1 ± 
4.2 years) vascular endpoints: nonfatal or fatal ischemic stroke, composite vascular 
endpoint, or death from any cause.
5.1.2 Effects of preceding infection (PI), (II)
Of our study population, within four weeks prior to their stroke 10% had suffered 
from PI. The most common type of infection was upper respiratory tract infection 
(54%). The less common infections were those of lower respiratory tract (11%), 
skin and mucous membrane (11%), and gastrointestinal organs (12.9%). Our study 
population had only a few chronic infections (6%).
Patients with PI, compared to those without PI, had significantly higher  CRP on 
admission (median 4 mg/L, intermediate range 3-23 mg/L vs 3 mg/L, intermediate 
range 3-6 mg/L, p<0.001). These patients with PI had higher values of CRP (median 
12 mg/L vs 3 mg/L, p<0.001), highest leukocyte count (10.1 x 109 cells/L vs 9.1 x 109 
cells/L, p=0.010), and highest body temperature (37.4ºC vs 37.1ºC, p=0.003). Some 
infection parameters measured on admission (the body temperature or leukocyte 
count on admission) were not associated with PI, however. The PI did not affect 
the length of stay in the hospital.
The only risk factor that was more common in patients with PI was heart failure 
(4.1% vs 11.4%, p=0.014). The other baseline variables in the univariate analysis 
were not associated with PI (TOAST, NIHSS, lesion size or territory).
In the multivariate analysis PI was independently associated with an unfavorable 
3-month outcome (OR 2.86; 95% CI 1.48-5.54; p=0.002). In the long-term follow-
up, PIs had no impact on any of the endpoints: recurrent ischemic stroke (log rank 
P=0.323), composite of vascular endpoints (p=0.157) or mortality (p=0.500) from 
any cause.
5.1.3 Effects of post-stroke infection (PSI), (II)
Of the included young stroke patients, 15% suffered from PSI. The most common 
focus in half of the patients with PSI (50%) was chest infection, of which most 
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frequently pneumonia. Genitourinary infections, most commonly urinary tract 
infection occurred in one third of the patients (35%). Patients who had PSI stayed 
for a longer period in the hospital compared to those, who did not have infections 
(20 days vs 10 days; p<0.001).
When compared with the young stroke patients without PSI, the conventional 
risk factors did not differ. History of migraine was slightly more common in patients 
with PSI (p=0.045). Their stroke characteristics were significantly different: they 
had more severe stroke symptoms (NIHSS 11 vs 3, p<0.001). In the brain scan, 
patients with PSI had significantly more frequently large infarction (64% vs 25%, 
p<0.001) and more often multiterritorial (11% vs 4%, p=0.002) or bilateral (42% 
vs 23%, p<0.001) than stroke patients without PSI. The main causes of stroke in 
patients with PSI were large artery atherosclerosis (compared to patients without 
PSI 13% versus 7%, p<0.001), high-risk cardioembolism (16% versus 10%, p<0.001) 
and carotid artery dissection (17% vs 7%, p<0.001). One third of all the included 
patients had a stroke of undetermined etiology (28% vs 31%). 
Most of the measured parameters for infections were significantly higher in 
patients with PSI: admission CRP and leukocyte count, highest measured CRP, 
leukocyte count, and body temperature (for all: p<0.001). The only exception, 
which did not differ whether or not the patient had a PSI, was the admission body 
temperature (p=0.983).
In the multivariate analysis, after adjustment for demographics, risk factors, 
stroke severity, and subtype, lesion size, presence of multiterritorial lesions, and PI, 
patients with PSI exhibited higher risk for unfavorable outcome when compared 
to those without PSI (OR 2.26; 95% CI 1.08-4.76; p=0.031).
In the long-term follow-up, patients with PSI did not have increased risk of 
recurrent ischemic stroke (log rank p=0.124) or composite of vascular events 
(p=0.170). Nevertheless, they continued to have higher mortality rate after exclusion 
of those who died within 30 days (p=0.002).
5.1.4 Effects of infections in multiple focuses or both PI and PSI (II)
Four patients had PI in multiple focuses. This did not affect their 3-month outcome 
in the univariate analysis. Altogether 13 patients had PSI in multiple focuses. This 
increased significantly their risk of an unfavorable outcome (OR 5.2, 95% CI 3.07-
8.8). There were 16 patients who suffered from both PI and PSI. They all had 
unfavorable 3-month outcomes.
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5.2 STROKE CHARACTERISTICS, FUNCTIONAL RECOVERY,  
 AND MORTALITY AFTER STROKE IN MALAWI
In QECH, 150 patients fulfilled the inclusion criteria and gave consent to the 
SOMA-study. Among them, three patients were excluded due to malignancy: one 
patient after the first brain imaging and two during the follow-up (Figure 6). The 
mean age of patients (53% males) was 54.2 ± 16.9 years. Almost all patients were 
independent before the onset of stroke (99% mRS=0-2). Hypertension was the 
most prevalent (55%) vascular risk factor, followed by diabetes mellitus (21%) and 
hypercholesterolemia (15%). Of the life style, smoking (18%) and heavy drinking 
(15%) were present. Electrocardiogram was recorded in 100 patients. It revealed 
in seven patients an atrial fibrillation. They were elderly patients (65.9 ± 12 years).
A brain scan was not done for 23 (16%) patients due to unavailability of the 
scan, CT or MRI. In the brain scan, 26% showed intracerebral hemorrhage (ICH). 
Most patients (87.5%) with ICH were hypertensive. The most common stroke type 
according to the Bamford criteria was partial anterior circulation stroke. Of them, 
36% had left hemisyndrome. The majority of patients (53.5%) had severe stroke 
symptoms when admitted to QECH. Stroke severity was strongly associated with 
older age but not with gender.
The mortality rate at six weeks was 28%. Most of them (22%) died during the 
first admission. The cumulative mortality rates at six months and one year were 39% 
and 45%, respectively. Older age (58.5 ± 16.6 vs 54.1 ± 15.4 years, p=0.013), female 
gender (55% females vs 37% males, p=0.035), and stroke severity on admission 
(mNIHSS ≥ 13, 60% mortality vs mNIHSS 0-12, 23% mortality, p<0.0001) were 
significantly related with higher mortality at one year. 
At one year, 47% of the study patients had a good or fair outcome (mRS=0-
3). Similarly, the mortality, and a poor outcome was associated with older age, 
female gender, and severe stroke at presentation. In multiple logistic regressions 
other independent determinants of poor functional outcome at one year were the 
female gender (OR 2.3 95% CI 1.0-5.5, p=0.05), and stroke severity at presentation 
(mNIHSS ≥ 3 OR 4.5 95% CI 1.7-11.8, p=0.002). During the one-year follow-up, 11 
patients had a recurrent non-fatal stroke. Secondary to stroke two patients developed 
epilepsy, and one of the stroke patients developed thalamic pain syndrome.
5.2.1 Stroke characteristics in HIV seropositive patients and effect  
 of HIV infection to the outcome (III)
HIV seropositive patients formed one third (34%) of all the patients. They were 
significantly younger when compared to HIV seronegative patients (39.8±12.4 vs 
61.9±14.0 years, p<0.0001). The majority of those below 55-years of age (65%) 
had HIV infection compared to those older than 55-years of whom 10% were HIV 
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seropositive. In our study population HIV infection was equally common in both 
men and women. They were less likely to have vascular risk factors like hypertension 
(24% vs 75%, p<0.0001) and diabetes (6% vs 25%, p=0.004). The HIV seropositive 
patients had more commonly anemia (11.8 ± 5.8 g/dl vs 13.6 ± 2.5 g/dl, p=0.0003). 
From the whole study population in 15 patients, of which five were HIV seropositive, 
presented with positive serological test suggesting syphilis (rapid plasma reagin).
Less common in HIV seropositive patients when compared to HIV seronegative 
stroke victims was ICH (11% vs 34%, p=0.004). Stroke severity was not associated 
with HIV status. There was no difference in MUAC between HIV seropositive and 
HIV seronegative patients (26.4±3.8 cm vs 27.3±4.2 cm). HIV seropositivity was 
not associated with the mortality or functional outcome (mRS) at one year.
5.2.2 Quality of life after stroke (IV)
Of the study population, 81 patients out of 147 were still in the study after six months. 
Mortality in the first six months was 52 patients and 14 patients had absconded. 
The majority of patients were men (58%). The mean age of patients was 54±16 
years. Majority of patients were married (69%), 15% were widowed, and the rest 
were single or separated. As at the start of the SOMA-study, most surviving patients 
(67%) had ischemic stroke.
Relocating after stroke primarily from urban to rural areas affected 22% of the 
study population. Mainly men (68%) returned back to their previous occupation. 
They were younger than other patients (47±15 years), but the two eldest returnees 
were 82-year-old and 79-year-old females.
NEWSQOL interview was conducted with 31% of the patients at the 6-month 
(18 patients) or 12-month (7 patients) visits. The main causes for exclusion were 
severity of index stroke (23 patients), no follow-up due to moving further away (15 
patients), or non-availability of Chichewa-speaking interviewer or interpreter at 
the time (14 patients). Thus, the patients who completed the NEWSQOL had less 
severe stroke, 48% vs 20% with mNIHSS 0-6 (χ2 for mNIHSS 0-6 vs mNIHSS ≥7 
=6.84, p=0.009), and better functional outcome, 80% vs 52% with mRS 0-2 (χ2 for 
mRS 0-2 vs mRS ≥ 3 =6.29, p=0.012), in 6-month follow-up compared to those 
who did not have the interview.
Despite being HI -seropositive, stroke severity at presentation or the civil status 
did not affect any domains of the QOL subgroup analysis.
The mean scores for all domains were between 70 and 86 of the total score of 
100. Patients with lower mRS at six months scored expectedly lower in the domains 
of ADL/self-care (95% CI -0.793 vs -0.238, p=0.0024) and communication (95% CI 
-0.707 vs -0.0453, p=0.0307) domains. Also as expected older age was associated 
with a worse QOL in the domain of ADL (95% CI -0.744 vs -0.122, p=0.0122). 
Females scored significantly lower than men in the domains of cognition (females 
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mean 67 ± SEM 8.5 vs males mean 85 ± SEM 4.4, p=0.05) and fatigue (females 
mean 63 ± SEM 9.8 vs males mean 91 ± SEM 2.9, p=0.01). The other domains: 
sleep, relationships, vision, and pain were not affected by any of the variables under 
investigation.
5.3 COMPARISON OF THE CHARACTERISTICS AND OUTCOME  
 BETWEEN YOUNG STROKE PATIENTS IN MALAWI AND   
 FINLAND (I, II, III)
Table 4 describes the characteristics and outcome of the study populations in the 
studies I, II and III. From the SOMA study (III) only the young stroke patients 
are included, the same age group, 18-49 years, which is comparable to the HYSR 
subjects. Malawian young stroke patients were relatively younger than their Finnish 
counterparts. HIV was prevalent amongst the Malawian young patients. They had 
more severe strokes. High leukocyte count was more common among the HYSR 
subjects. Hypertension was the most common conventional risk factor. Smoking, 
obesity, and hypercholesterolemia were more common amongst the Finnish stroke 
patients.
Table 4. The characteristics of young stroke patients and outcome of stroke in Malawi and Finland. 
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Item / unit 






age / years 
mean±SD 35.0 ± 7.7 41.4 ± 7.6 41.4 ± 7.6 
Males / % 52.2 62.1 62.3 
NIHSS / median (range) 11 (0 – 29) 3 (0 - 35) 3 (0-35) 
Tax / ºC 
mean ± SD 37.0 ± 1.0 (n=45) 36.6 ± 0.6 36.6 ± 0.6 
s-leuk /   
mean ± SD 6.0 ± 3.1 (n=36) 8.9 ± 3.1 8.9 ± 4.0 
HIV / % 73.9 0 0.1 
Hypertension / % 22.7 (n=44) 38.8 37.4 
DM / % 8.7 (n=43) 10.1 10.3 
Chol / % 13.0 (n=36) 58.9 58.4 
Smoking / % 11.1 (n= 45) 43.7 43.9 
heavy drinking / % 13.3 (n=45) 14.5 14.8 
obesity BMI/MUAC % 2.2 11.4 11.0 
underweight/MUAC % 21.7 NA NA 
PI / % 28.2 13.3 10.3 
PSI / % 15.2 NA 15.1 
mRS 0-1 at 3 months / % 8.7 47.9 47.3 
mRS 2-6 at 3 months % 78.3 52.1 52.7 
Death (mRS=6) at 3 
months % 10.9  4.2 3.5 
mRS NA at 3 months % 13.0 0 0 
N indicates the number of patients and is marked if it is different than the whole study group. NA 
indicates the non-availability of the information. In heavy drinking: observe the different definitions 
in Finnish and Malawian studies.  
Muotoiltu taulukko
N indicates the number of patients and is marked if it is different than the whole study group. 
NA indicates the non-availability of the information. In heavy drinking: observe the different 
definitions in Finnish and Malawian studies.
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5.4 LONG-TERM FUNCTIONAL OUTCOME OF HIV  
 SEROPOSITIVE PATIENTS (V)
The number of HIV seropositive patients that were managed in the outpatient 
clinic of Aurora increased from 98 in 1986 to 248 in 1991. Following screening and 
exclusions we included 80 patients in our study from 1986-1990. Mainly due to 
high mortality rate 23 patients were re-investigated during 1997 and only 17 were 
evaluated in the year 2013. All the followed patients were men and their median 
age in 2013 was 59 (range 46-75) years. They had high level of education, mean 
time of formal studies being 13 years. Alcohol abuse was an exclusion criteria in the 
beginning of the screening and none of these HIV seropositive men had increased 
their drinking in subsequent years. Smoking was a habit amongst seven patients and 
one patient admitted smoking marijuana occasionally. Fatigue (FSS >37) was found 
in nine patients according to the fatigue severity scale. Depression was diagnosed and 
treated in four patients. BDI – results did not vary during the times of examination: 
results were 4.65, 5.53, and 5.00, respectively indicating mild depressive symptoms. 
Hypertension was medicated and treated in five men; diabetes was diagnosed in two 
subjects. Nephropathy was also diagnosed in two patients, one caused by diabetes 
and the other by prostatic hyperplasia. Hypercholesterolemia was diagnosed and 
medicated in 11 patients. 
The HIV seropositive men estimated that the time of infection occurred 28 (range 
23-31) years ago. Most of them were infected through homosexual contact. None of 
the patients were iv-drug abusers. The median time from diagnosis of HIV was 27 
(23-30) years. The median of blood CD4 count measured during the first year from 
diagnosis was within normal reference range: 680 cells/mm3 (range 29-870 cells/
mm3). Low nadir CD4 level (<200 cells/mm3) was found in 11 patients. The AIDS-
defining disease was found in three patients, all before the start of cART. At present 
they all have cART, the median years on the cART being 13 (5-17) years. More than 
half of the patients had had cART for more than 10 years with successful continuous 
virological suppression. Altogether the study population had used antiretrovirals for 
19 (9-24) years. None of the participants had antibodies against hepatitis C virus. 
HBcAb was positive in five patients indicating that they have had earlier hepatitis 
B infection while none of the patients had reactive HBsAg which would mean being 
a carrier of the virus. One patient was treated for syphilis due to positive serology 
(TPHA = 640, cardiolipins = 4)
In the neurological evaluation the EDSS median was 2.0 (range 1.0-4.0) 
indicating minimal disability. Four of the patients had a diagnosis of neuropathy. 
On the neurological examination these four and one additional patient had signs of 
neuropathy (Sensory FS 3.0-4.0). Moderate disability was also found in one patient, 
who had mild extrapyramidal signs and bladder dysfunction that increased his 
EDSS. None of the patients had loss of vision, cerebellar ataxia, prominent pyramidal 
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symptoms or other clinical signs of central nervous system abnormalities. They 
were all fully ambulatory. Most of the patients (16) had intact sensation of smell.
The neuropsychological results indicate changes especially between 1997 and 
2013. All of these changes are typical for the aging brain: visuospatial processing 
weakens, memory functions worsen and the ability for speed and flexibility decreases.
The results of neuroimaging in 1997 and 2013 were compared: one patient had 
developed white matter changes indicating vascular degeneration or small vessel 
disease in the brain parenchyma (change of grade 1 to grade 2 in Fazekas scale). 
He also had lacunar infarctions and microbleeds in brain. One patient had signs of 
lacunar infarct already in 1997. Another patient had one lacunar infarction in 1997 
and now had another one. None of these patients had had CNS symptoms or signs 
of stroke in their history. Four subjects had nonspecific T2-signal enhancements. 
Two patients had increasing atrophy in the brain one of which was measured the 
bicaudate ratio: 0.12 – 0.13 cm and the other measured the width of the third 
ventricle: 0.57 – 0.68 cm. Completely normal brain parenchyma was found in 
seven patients. One patient refused the MRI.
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6 DISCUSSION
6.1 THE EFFECT OF INFECTIONS ON THE OUTCOME  
 OF YOUNG STROKE VICTIMS (I, II)
In our young Finnish patients with acute stroke, the mean leukocyte count was 
above the laboratory reference range, thus, high leukocyte count was common. In 
the elderly stroke patients, high leukocyte count was associated with an unfavorable 
outcome.123 In our investigation, the prevalence of infections before the event of 
stroke and after the stroke were 10% and 15%, respectively. In previous studies 
of PI and young stroke victims (under 50 years), the frequency is higher than in 
ours: 39%.100,211 In the study of Grau et al, the prevalence of PI was markedly lower 
in the patients older than 50-years.211 The higher leukocyte count, PI, and PSI all 
caused unfavorable 3-month outcome in our young patients with stroke. Only 
the infections after stroke affected the long-term mortality and risk of vascular 
events. There is strong evidence that PSI worsens the prognosis of acute stroke in 
elderly study populations from previous studies.113-115,212 Symptomatic atherosclerosis 
is uncommon in young stroke patients, but its pathogenesis starts already at a 
young age. Some atherosclerotic findings are prevalent in arteries already in 
young stroke victims and the stroke risk starts to increase at early middle age.213 
Inflammatory processes can cause ischemic stroke.93,94,99,100,106 Existing intracranial 
atherosclerosis may disturb the salvage of penumbra of ischemic lesion.  Even in 
healthy children it has been observed that infection, even a mild one, can cause 
endothelial dysfunction.104 This could explain why infections can trigger stroke in 
patients without overt atherosclerotic pathogenesis. In our study, higher leukocyte 
count was associated in exploratory multiple regression to dyslipidemia, smoking, 
and peripheral arterial disease (atherosclerosis). Low rate of atherosclerosis could 
explain why high leukocyte count was not predicting long-term poor outcome.13,22,44
Arterial dissection is the most common cause of stroke in the young.22,24,44 It might 
be caused by vessel wall inflammation that is triggered by PI. These patients might 
even have a more generalized inflammatory process in their arterial endothelium 
leading to arteriopathy.49 Further conventional risk factors, such as dyslipidemia, 
hypertension, and smoking activate the inflammation, cause increased levels of 
leukocytes, and activate the monocytes leading to endothelial inflammation.42,43,214 
Endothelium of the arteries is also part of the neurovascular unit that plays a part in 
regulating the inflammation in ischemic stroke.215 This dysfunction of endothelium 
could partly explain the lower odds of good short-term recovery in our patients 
with PI or high leukocyte count. PI did not affect the long-term outcome, which is 
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likely due to the transient nature of often banal acute upper respiratory infection 
that only acts as a trigger of stroke.
The association between the higher leukocyte count and increased stroke 
severity or larger infarct size is, as shown in our study, a known finding also in 
previous investigations with the elderly population.43,121,122,125,127,216 Ischemic lesion 
causes a strong inflammatory reaction that can increase the leukocyte count in the 
blood.43,93,121,125,127,216-218 The larger lesion size causing inflammation partly explains 
why the high leukocyte count at the acute phase of ischemic stroke is predicting  a 
poor outcome at three months. 
There is solid evidence that PSI is linked with the unfavorable outcome.113-115,212 
Our study confirms this finding also in the young stroke victims. PSI was more 
frequent in patients with more severe stroke symptoms and larger lesion size also 
in our investigation.110,111,219 Further, it was associated with other inflammatory 
parameters like the higher leukocyte count, CRP, and higher body temperature. It 
was the only inflammatory factor in this investigation that affected the long-term 
risk of vascular events and mortality. PSI like all other hospital acquired infections 
has a negative impact on prognosis of patients. Preventing these infections can 
improve the outcome of a stroke patient.
6.2 STROKE OUTCOME IN SUB-SAHARAN AFRICA (III, IV)
In Malawi, the conventional vascular risk factors were prevalent especially in patients 
who were older than 55 years of age. Hypertension was the most prevalent risk 
factor (55% of patients) as in many previous studies from the region.72,75 DM was 
present in 20% of our patients and hypercholesterolemia in 15% of the patients. 
Compared to the general population of Malawi, the prevalence of increased blood 
pressure, glucose, and cholesterol were 32%, 6%, and 10%, respectively.220 Obesity 
was as prevalent as in the general adult population in Malawi where 5.5% has BMI 
more than 30.220 The rate of smoking and excessive drinking was slightly lower than 
expected according to the recent Malawian survey. 
When the prevalence of the vascular risk factors is compared to other studies 
from SSA, the proportion of diabetic patients with stroke is higher than that reported 
in other research from the African region where the DM-prevalence was 0-15%.75,221
HIV infection was very prevalent in our younger stroke victims. The average age 
of HIV-infected stroke patients was 39.8 years. In many of them, stroke was the 
first indicator of the HIV infection, the WHO clinical signs of HIV infection were 
not present.222 They had less severe strokes than the older study patients. Ischemic 
stroke was more common in this subgroup. Interestingly, four out of seven patients 
with atrial fibrillation (AF) were HIV-seropositive which could be a sign of HIV-
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related cardiomyopathy in the older HIV-infected patients. In all, there is very scarce 
research about the relationship of stroke and infection in SSA.
Most (22 patients) HIV seropositive patients had low CD4 count indicating 
that they were eligible for the effective therapy (cART) according to the national 
program in Malawi.223 However half of them did not start cART. Five patients 
had started cART within 5 months prior to their stroke. This could mean that 
the ischemic stroke was a sign of immune reconstitution inflammatory syndrome 
(IRIS) in these patients.85 IRIS describes an inflammatory disorder associated with 
paradoxical worsening of pre-existing infectious processes following the initiation 
of cART. Few patients with cART had a CD4 count <100 cells/mm3, suggesting 
a possible treatment failure. Some cART medication increases the possibility of 
vascular risk factors.224
The main determinants of an unfavorable 1-year outcome were the severity of 
stroke symptoms at the acute phase and the female gender. Our female patients 
did not have more prevalent AF, different acute therapy, or older age, which 
have been associated with the female stroke patients’ worse prognosis in another 
investigation.221 Most likely, in Malawi and some other resource-poor African 
countries, the socio-demographic factors can explain the unfavorable outcome in 
women with stroke.71 Case-fatality is high when compared to European countries, 
but slightly lower when compared to other studies from SSA.71 The severity of stroke 
on admission is usually higher than in the western world because in SSA people 
with mild stroke symptoms do not seek medical help or are not admitted to hospital. 
The medical system does not provide any outpatient follow-up or care. Family 
members, often women, play an essential role in vital issues such as with fluid and 
food intake, hygiene, and mobilization.
Our patients scored in NEWSQOL interview generally higher, meaning better 
QOL, than their European counterparts.225,226 This could be explained by selection 
bias but also due to cultural differences. We found that female gender was negatively 
associated with QOL in the domains of cognition and fatigue. In other Sub-Saharan 
African studies from Nigeria, gender did not affect the post-stroke QOL.89,90,227 The 
prevalence of post-stroke depression was higher in women in a South American 
study, and the depression was associated with disability and lower cognitive 
functioning.228 In SSA, family participation in hospital and home care is essential 
for both survival and quality of life after stroke.
.2 Stroke outcome in Sub-Saharan Africa (III, IV)
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6.3 THE EFFECT OF LONG TERM HIV INFECTION IN SURVIVORS  
 WITH BEST AVAILABLE THERAPY (V)
Development of cART and the patients’ compliance with therapy help to preserve 
their neurological and neuropsychological capability. This study, following HIV-
infected patients for three decades, revealed no significant signs of CNS impairment 
or development of HAND. Many of the results can be explained by normal aging.
HIV affects the CNS in many ways.229,230 The infected astrocytes can cause increase 
of glutamate-levels due to reduced uptake. The cells can also alter the blood-brain 
barrier more permeable and contribute to the generation of HIV reservoir in the 
CNS. The astrocytes can affect the non-infected astrocytes and destroy them through 
apoptosis. The latent CNS HIV infection and high levels of HIV in CNS is associated 
with HAND. 
Since 1996 cART and viral suppression have been commonly available in Finland. 
Prior to then, our patients experienced mild or severe immunosuppression and 
even AIDS symptoms. Since most of our patients have been on the best available 
treatment for more than a decade, no symptoms of HAND emerged. Only 
neuropsychological examination can differentiate mild forms of HAND from early 
Alzheimer’s disease.182 One of our patients had some extrapyramidal signs, but 
apart from this, clinical examination found no CNS impairment. Extrapyramidal 
symptoms are rarely related to HIV infection. The only significant neurological 
impairment that was evident in our study population was peripheral neuropathy 
resulting from HIV infection itself, cART medication, or even diabetes in a few 
patients.180
In the USA, the CHARTER study investigating HIV seropositive patients found 
some signs of neuropsychological impairment in 52%, with even HAD emerging in 
2%.185  Of their 1555 subjects, 28% were using some recreational drugs. Our patients, 
however, did not use such drugs. This may in part explain the good outcome in 
our patients. The risk for HAND-like symptoms increases with co-infection with 
hepatitis C.231,232 No-one in our study cohort had hepatitis C antigens. This can 
also explain their good neurocognitive outcome. Another benefit acting against 
development of neurocognitive diseases was that our study cohort individuals were 
well educated. 
The prevalence of hypercholesterolemia amongst our patients can be explained 
by a well-known side-effect of antiretroviral medication, especially protease 
inhibitors.149,233 The prevalence of other conventional risk factors for stroke was 
similar to that of the general population in Finland. That diabetes, hypertension, and 
hypercholesterolemia were treated appropriately also reduced risks for neurological 
and neurocognitive defects. Signs of silent strokes in MRI of our patients support 




In young stroke patients, who have less conventional risk factors, the contributing 
effect of infections may be more pronounced. A prospective study is needed, where 
the history of PIs is carefully checked from the stroke patients or their next-of-kin, 
and serology and plasma biomarkers of infections collected. Understanding and 
controlling the inflammatory processes and infections would help us to develop 
new treatments. This would help us to learn about the different stroke subtypes, 
including those young stroke victims with no overt cause of stroke. Could therapies 
against inflammation be neuroprotective during the phase of the first months after 
stroke? In a recently published trial, intravenous minocycline was a safe method but 
the sample size was too small to show efficacy.234 According to the recent review and 
PASS-study, however, the preventative antibiotics immediately after stroke reduce 
the amount of PCIs but do not shorten the admission time or affect the outcome.120 
The researchers are discussing whether PCI is a sign of other condition causing 
unfavorable outcome and treating the PSI with antibiotics does not remove the 
‘hidden’ cause. In rats, a drug called 3.6’-dithiotalidomide reduces the stroke size, 
reduces the inflammatory process, and improves the outcome.235
The prevalence of noncommunicable diseases is increasing in many Sub-Saharan 
countries.68 In the treatment protocols and treatment possibilities, however, no 
development in same pace has occurred. In these countries, health budgets should 
prioritize the health education and treatment of hypertension, DM, and cessation of 
tobacco smoking. Malawi has a national program for cART access.223 Despite this 
too many stroke patients are not on cART probably due to mobility problem caused 
by the stroke or not understanding for the need. We should understand that HIV 
infection could be an independent risk factor for ischemic stroke in young people. 
Patients with good compliance to cART, decent nutrition, and healthy lifestyle, can 
stay in proper cognition and condition even decades.
6.5 STRENGTHS AND LIMITATIONS OF OUR STUDIES
As far as we know, the Finnish HYSR studies (I and II) are the first ones to study 
the outcome of young stroke patients with infections. The study population is fairly 
large and well-investigated, and the follow-up is long. These studies are, however, 
retrospective covering almost a ten-year time period while the diagnostic methods 
and treatments of strokes have improved. Admission protocol omitted more detailed 
laboratory tests for inflammation, such as a high sensitivity-CRP or differential cell 
count of leukocytes. These studies were hospital-based, nevertheless, almost all 
young stroke patients from our catchment area are admitted and treated in HUCH.
.   i tio s
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In resource-limited countries like Malawi, patients do not come to any health 
facility when they develop stroke symptoms (III). Patients invariably stay home with 
mild stroke symptoms. Moreover those with the most severe strokes are kept at 
home. QECH has limitations with diagnostics and treatment. Equipment, including 
ECG or CT, was out of order without possibility of becoming functional within time 
frame of our study. We also lacked sufficient trained staff, such as Chichewa-speaking 
interviewer for our QOL study (IV). Due to these facts the QOL study selection 
became biased: some solely Chichewa speaking patients were not interviewed. One-
year follow-up succeeded in most of our study patients (90%). Differences in in-
hospital and one-year mortality compared to other studies from the region suggest: 
at the baseline our recruitment criteria was comparatively different and our stroke 
diagnosing was more meticulous.71,76,77
In Finland our study about long-term outcome of HIV infection the sample 
size is small in numbers (V). Before the onset of cART the disease was having a 
devastating effect. It may well be that our population of survivors represents a 
subgroup of HIV-1-infected persons who tolerate HIV-1 infection better than men in 
the average. Further, they were all well-educated and maintained good compliance 
throughout the years. Our study population might present a survival bias of the 
original population. On the other hand, the original study population represents 
prominent part of the HIV-infected population in Finland during 1980s. It is also 
the first study in the world as far as we know where HIV patients are followed-up 
for this length of time.
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7 SUMMARY AND CONCLUSIONS
In our young stroke patients a common finding was high leukocyte count. Higher 
leukocyte count was independently associated after three months with a worse 
functional outcome. In the long-term follow-up, high leukocyte count had no 
association with the risks of future vascular events or mortality. Of our stroke 
population, 10% had a preceding infection and 15% developed an infection early 
on after the onset of stroke. According to our results, interestingly, both PI and 
PSI independently almost doubled the risk of an unfavorable 3-month outcome 
of stroke. Only PSI influenced the mortality or risk of vascular events after several 
years from stroke.
In the Sub-Saharan country of Malawi, the elderly stroke population commonly 
had conventional vascular risk factors present while young stroke victims were 
more often, without any other known risk factors, HIV seropositive. HIV infection 
did not affect the one-year outcome. The main determinants of an unfavorable 
outcome were severe symptoms of acute stroke and female gender. An effective 
treatment policy for non-communicable diseases in the countries of SSA would 
reduce significantly the risk of stroke. These countries have a unique opportunity 
to take the risk of increasing vascular diseases seriously and reduce the risk of 
stroke by acting accordingly through primary health care methods, and primary and 
secondary prevention. Improving the post-stroke care will reduce the case fatality 
and disability caused by stroke.
HIV seropositive men, even after the AIDS-phase, can recover and maintain their 
good health and cognition when they have the best available treatment, for longer 
than 25 years after the infection. The most significant neurological impairment 
was polyneuropathy. The results of the neuropsychological investigation only 
showed signs of normal aging. In conclusion our results give credence to the view 
that starting appropriate medication on time, delivering the therapy effectively, 
and taking care of other conditions that may threaten the brain, the HIV-infected 
persons may preserve their neurocognitive function. It would be interesting to do 
further investigations with the HIV-infected stroke patients: what are the related 
causes in the Finnish HIV population. Studies with high-quality data would guide 
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The 11 domains and 56 items of NEWSQOL
Domain Item Response options
Feelings
Do you feel less independent than you were, 
because of the stroke?
No, a little less, quite a lot 
less, very much less
Has the stroke changed the way you feel about 
yourself?
No, a little, quite a lot,  
a great deal
(If yes): And can I just check, would you say that 
the change is for the better or for the worse?
For the better, for the worse
To what extent would you say your life has 
changed because of the stroke?
Not at all, a little, quite a lot, 
a great deal
(If yes): And again, would you say that the change 
is for the better or for the worse?
For the better, for the worse
Does the stroke make you feel useless at all? No, a little useless, fairly 
useless, completely useless
Do you feel you have less control over what is 
happening in your life because of the stroke?
No, a little less, a lot less,  
no control at all
Do you feel depressed because of the stroke? No, occasionally, sometimes, 
always
ADL/self-care
Because of the stroke, do you have difficulty 
preparing food, for example cutting a slice of bread 
or cutting up vegetables?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you have difficulty with housework because of 
the stroke? 
No, some difficulty, a lot of 
difficulty, can’t do it at all
Because of the stroke, do you have difficulty with 
cooking?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you have difficulty managing the shopping 
because of the stroke?
No, some difficulty, a lot of 
difficulty, can’t do it at all
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Because of the stroke, do you have difficulty using 
public transport (for example getting on and off, 
holding on to steady yourself)?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you have difficulty getting washed by yourself 
because of the stroke?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Because of the stroke, do you have difficulty 
getting dressed by yourself, including things like 
zips and buttons?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you have difficulty getting in/out of the bath or 
shower on your own because of the stroke? 
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you find it difficult to concentrate for long 
because of the stroke?
No, a little difficult, quite 
difficult, very difficult
Because of the stroke, are there times when you 
forget what you have said or what people say  
to you?
No, occasionally, sometimes, 
always
Because of the stroke do you find it difficult  
to solve problems or make decisions?
No, a little difficult, quite 
difficult, very difficult
Would you say you keep forgetting things because 
of the stroke?
No, occasionally, sometimes, 
always
Because of the stroke, do you find it difficult  
to think clearly?
No, a little difficult, quite 
difficult, very difficult
Mobility 
Because of the stroke, do you walk with a stick or 
frame or by holding onto things?
No, sometimes, always,  
can’t walk
Because of the stroke, do you have difficulty 
standing for any length of time?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you find that you are unsteady on your feet 
because of the stroke?
No, quite unsteady, very 
unsteady, can’t stand
Do you feel as if you walk slowly because of  
the stroke? 
No, quite slowly, very slowly, 
can’t walk
Because of the stroke, do you have any difficulty 
walking half a mile
No, some difficulty, a lot of 
difficulty, can’t do it at all
Because of the stroke, do you have any difficulty 
walking up or down hills?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you have difficulty managing stairs on your own 
because of the stroke?
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you have difficulty bending down because of 
the stroke? 
No, some difficulty, a lot of 
difficulty, can’t do it at all
Do you get around in a wheelchair because of  
the stroke?




Do you get more emotional because of the stroke? No, a little more emotional, 
more emotional,  
quite a lot more emotional, 
very much more emotional
Do you sometimes cry at the least thing because  
of the stroke?
No, occasionally, sometimes, 
always
Are you worried that you could have another 
stroke?
No, a little worried, quite 
worried ,very worried
Because of the stroke, do you worry about 
becoming dependent on other people?
No, worry a little, worry 
quite a lot, worry a great 
deal
Sleep  
Do you have problems sleeping at night because  
of the stroke?
No, occasionally, sometimes, 
always
Because of the stroke, do you sometimes wake up 
too early?
No, occasionally, sometimes, 
always
Do you have difficulty getting off to sleep because 
of the stroke?
No, occasionally, sometimes, 
always
Do you ever feel exhausted because of the stroke? No, occasionally, sometimes, 
always
Do you feel that you lack energy because of  
the stroke?
No, occasionally, sometimes, 
always
Do you find you need a lot of rest because of  
the stroke?




Are you short-tempered because of the stroke? No, a little short-tempered, 
quite short-tempered,
very short-tempered
Has the stroke put any strain on your relationship 
with your spouse or partner?
No, a little strain,  
quite a lot of strain,
a great deal of strain
Because of the stroke, do you argue more with 
close friends or family?
No, a little more often,  
a lot more often,
argue all the time
Are you less tolerant because of the stroke? No, a little less tolerant, quite 
a lot less, very much less
Does the stroke interfere with your sex life and if 
so, how much?
No, a little, quite a lot,  
a great deal
Because of the stroke, have you become nervous 
about meeting people?




Do you feel as though your speech is slurred at all 
because of the stroke?
No, a little slurred, quite 
slurred, very slurred
Do you find it difficult to make yourself understood 
because of the stroke?
No, a little difficult, quite 
difficult, very difficult
Because of the stroke, are there times when you 
have difficulty expressing yourself?
No, occasionally, sometimes, 
always
Do you have any difficulty with writing because of 
the stroke? 
No, some difficulty, a lot of 
difficulty, can’t write at all
Pain/sensation
Do you have any pain because of the stroke? No, a little pain, quite a bit 
of pain, a lot of pain
How often do you have pain because of the stroke? Never, occasionally, 
sometimes, often
Because of the stroke, do you have difficulty 
picking up small things?
No, some difficulty, a lot of 
difficulty, can’t write at all
Vision
Do you have problems with your eyesight because 
of the stroke?
No, slight problems, 
moderate problems, 
severe problems
Do you have any difficulty with reading because of 
your eyesight (check: because of the stroke)?
No, some difficulty, a lot of 
difficulty, can’t read at all
Fatigue 
Do you doze off during the day because of the 
stroke?
No, occasionally, sometimes, 
always
Because of the stroke, are there days when you feel 
you could sleep all the time?
No, occasionally, sometimes, 
always
Because of the stroke, do you feel that you can’t be 
bothered with things at times?
No, occasionally, sometimes, 
always
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APPENDIX 2  
FATIGUE SEVERITY SCALE ENGLISH AND FINNISH VERSIONS
Fatigue Severity Scale (FSS) 
  Completely disagree
            Completely 
            agree
1. My motivation is lower when I am 
fatigued 1 2 3 4 5 6 7
2. Exercise brings on my fatigue 1 2 3 4 5 6 7
3. I am easily fatigued 1 2 3 4 5 6 7
4. Fatigue interferes with my physical 
functioning 1 2 3 4 5 6 7
5. Fatigue causes frequent problems for me 1 2 3 4 5 6 7
6. My fatigue prevents sustained physical 
functioning 1 2 3 4 5 6 7
7. Fatigue interferes with carrying out 
certain duties and responsibilities 1 2 3 4 5 6 7
8. Fatigue is among my 3 disabling 
symptoms 1 2 3 4 5 6 7
9. Fatigue interferes with my work,  
family or social life 1 2 3 4 5 6 7
Individuals are instructed to choose a number from 1 to 7 that indicates their degree of agreement 




Tällä asteikolla arvioidaan uupumuksesi määrää. FSS on lyhyt kysely, jossa Sinun 
pitää arvioida uupumustasi.
FSS sisältää yhdeksän väitettä. Lue jokainen väite ja ympyröi joku numeroista 1-7, 
riippuen siitä, kuinka täsmällisesti se sopii vointiisi viimeisen viikon aikana ja oletko 
samaa tai eri mieltä toteamuksen kanssa.
• Numero yksi tarkoittaa että olet täysin eri mieltä väitteestä.  
Numero seitsemän tarkoittaa, että olet täysin samaa mieltä.
• Muista ympyröidä jokaisen väitteen kohdalla vain yksi numeroista.
FSS väitteet:
Viimeisen viikon aikana olen huomannut, että:
  Eri mieltä Samaa mieltä
1. Motivaationi on alempi, kun olen 
uupunut. 1 2 3 4 5 6 7
2. Liikunta lisää uupumustani. 1 2 3 4 5 6 7
3. Uuvun helposti. 1 2 3 4 5 6 7
4. Uupumus alentaa toimintakykyäni. 1 2 3 4 5 6 7
5. Uupumus aiheuttaa minulle usein 
ongelmia. 1 2 3 4 5 6 7
6. Uupumus estää pitkäkestoisen fyysisen 
toiminnan. 1 2 3 4 5 6 7
7. Uupumus häiritsee tiettyjen tehtävieni 
hoitamista. 1 2 3 4 5 6 7
8. Uupumus on yksi kolmesta pahimmasta 
oireestani. 1 2 3 4 5 6 7
9. Uupumus häiritsee työ-, perhe-, tai 
sosiaalista elämääni. 1 2 3 4 5 6 7
Kokonaispisteet:          /63
